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This dissertation research sought to determine whether the proportion of 
physicians using electronic prescribing (e-prescribing) was associated with the 
hospitalization rate for adverse drug events (ADEs) among patients aged 65 and older in 
2011.  Additionally, we sought to determine whether increases in the proportion of e-
prescribing physicians in a county were associated with decreases in the hospitalization 
rate for ADE among older adults. 
Methods.  
Two study designs were used, a cross-sectional study using 2011 data and a pre- 
post- study using 2008 and 2011 data. Data from the 2008 and 2011 State Inpatient 
Databases, the Office of the National Coordinator Health IT Dashboard, and the Area 
Health Resource File were gathered for six states: Arizona, Florida, Maryland, Michigan, 
New Jersey, and Washington. ADE hospitalization rates were calculated for adults 65 
years and older. The independent variable, the rate of e-prescribing, was an ecological 
measure for both analyses. Multivariable linear regression examined county rates of ADE 
hospitalization in 2011, multivariable logistic regression examined the odds that a 
discharge would have been ADE associated versus other causes in 2011, and negative 
binomial regression was used to model the ADE hospitalization rate among older adults 





Results indicated that county e-prescribing rates were not significantly associated 
with county ADE hospitalization rates among older adults (p=0.4705). Further, after 
adjusting for patient, provider, health infrastructure, and community factors, the county e-
prescribing rate was not a significant factor in determining the odds of an ADE 
hospitalization. Change in e-prescribing rates was not significantly associated with the 
change in ADE hospitalization rates; no other county characteristics were found to be 
significant factors.  
Conclusion.  
Though the adoption of e-prescribing has continued to increase throughout the 
U.S., our findings indicate that population-level benefits, such as decreased ADE 
hospitalization among older adults, have yet to be seen. It may be too early to detect 
population-level changes due to low levels of implementation of health information 
technologies, such as e-prescribing. Researchers and policy makers must continue to 
monitor the population impact that the implementation of HITs is having on the health of 
the nation.  
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Focusing on improving patient safety and the quality of health care provision in 
the United States, the Institute of Medicine (IOM) has published To Err is Human: 
Building A Safer Health System (1999) and Preventing Medication Errors: Crossing the 
Quality Chasm Series (2007). Both reports discussed and provided potential strategies to 
reduce medication errors, adverse drug events, and/or potential drug events (Institute of 
Medicine, 1999, 2007). One such strategy is electronic prescribing (e-prescribing) 
defined as an electronic transmission of “an accurate, error-free and understandable 
prescription directly to a pharmacy from a point-of-care” (Centers for Medicare and 
Medicaid Services, 2014).  
Several key pieces of legislation during the past two decades have encouraged the 
adoption of e-prescribing by health care providers. The initial movement toward adoption 
of e-prescribing began with the Medicare Modernization Act (MMA) of 2003 and the 
2007 IOM report, Preventing Medication Errors: Crossing the Quality Chasm Series 
(Centers for Medicare and Medicaid Services, 2014). In 2008, Section 132 of the 
Medicare Improvements for Patients and Providers Act (MIPPA) created an incentive 
program for eligible professionals that were electronic prescribers. Most recently the 
Health Information Technology for Economic and Clinical Health (HITECH) Act, part of 
the American Recovery and Reinvestment Act (ARRA) of 2009 created the Medicaid and 
Medicaid EHR Incentive Programs to be administered by the Centers for Medicare and 
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Medicaid Services (CMS) for the “meaningful use” of health information technology 
(HIT), including e-prescribing capabilities (Centers for Medicare and Medicaid Services, 
2010). 
 Billions of dollars are being spent to aide physicians in the adoption of health 
information technologies. There has been a significant increase from 33% physicians 
adoption e-prescribing in 2009 to 73% of physicians in 2012 (King, Patel, & Furukawa, 
2012). It is essential that we demonstrate the impact of the adoption of e-prescribing on 
patient outcomes.  
Adverse drug events (ADEs) occur when prescription medications cause patient 
injury or harm. ADEs have public health importance because of the high numbers of 
Americans taking prescription drugs, particularly older Americans. During 2007-2010, 
approximately 40% of Americans aged 65 years and over managed five or more 
prescription drugs in the past 30 days; an increase from 28% during 1999-2002 (U.S. 
Food and Drug Administration, 2013b). In the past decade the Food and Drug 
Administration Adverse Event Reporting System (FAERS) reports a continued increase 
in the number of reported adverse drug events (U.S. Food and Drug Administration, 
2013b) and serious patient outcomes (U.S. Food and Drug Administration, 2013a). 
Researchers have also seen an increase in ADEs over time (Bourgeois, Shannon, Valim, 
& Mandl, 2010; Budnitz et al., 2006). The number of ADEs reported in U.S. hospitals 
increased 52% between the years of 2004 and 2008 (Lucado, Paez, & Elixhauser, 2011).  
 ADEs are seen among older adults nearly 7 times more often than among adults 
younger than 65 years (Budnitz et al., 2006). In this patient population, ADEs are an 
important indicator of patient safety. These adverse events have been associated with an 
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increase in the length of hospitalization, resource utilization, expense, and risk of 
mortality (Budnitz et al., 2006; Classen, Pestotnik, Evans, Lloyd, & Burke, 1997; Field et 
al., 2005). Recent estimates suggest that approximately 99,600 older adults are 
hospitalized each year due to ADEs (Budnitz, Lovegrove, Shehab, & Richards, 2011).  
 As the number of providers that e-prescribe and exchange clinical health 
information continues to rise, it is important to evaluate the impact these changes are 
having on patient outcomes, such as ADEs. The literature on the impact of health 
information technologies on ADEs is still in its infancy. The majority of literature in this 
area is conducted within inpatient settings and lack generalizability. The proposed study 
provides a population-based approach to examine the association of e-prescribing 
community-based physicians on ADE hospitalizations among older Americans (age 65 
and older). The specific aims of the study are: 1) determine the relationship between the 
percentage of physicians in a county using electronic prescribing (e-prescribing) and 
county-level rates of ADE hospitalizations among patients 65 years and older; and 2) 
determine the association between 2008 – 2011 change in percentage of physicians using 
electronic prescribing (e-prescribing) and change in county-level rates of ADE 
hospitalizations among patients 65 years and older. It is anticipated that a higher 
percentage of e-prescribing physicians will be associated with a lower rate of ADE 
hospitalization among the population of interest. 
 This dissertation is formatted using the manuscript style; Chapters 4 (Results) and 
5 (Conclusions) will be replaced with two manuscripts representing the two specific aims 
examined. Chapter 2 provides a review of scholarly literature in patient safety indicators, 
health information technologies, e-prescribing, and previous research in that examines the 
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intersection of health information technology and patient safety. Chapter 3 provides an 
overview of the methodology utilized to examine the two study aims of this dissertation 
research. Chapter 4 explores the association between electronic prescribing and adverse 
drug event hospitalization rates at a cross-sectional ecological and discharge-level, while 
Chapter 5 explores a similar association but examines the change between 2008 and 





National Focus on Quality and Patient Safety 
For several decades, healthcare has focused on providing quality care and 
ensuring patient safety. The 1999 Institute of Medicine (IOM) report, To Err Is Human, 
illustrated the need for a safer healthcare system. The report estimated between 44,000 
and 98,000 patients die as a result of medical errors each year (Institute of Medicine, 
1999). This estimate landed medical errors among the top 10 leading causes of death in 
the United States and costs the healthcare system between $17 billion and $29 billion. To 
Err Is Human provided several recommendations to decrease the number of medical 
errors occurring in the U.S. healthcare system (Institute of Medicine, 1999). These 
recommendations centered around: establishing a national focus on patient safety; 
identifying and learning from medical errors; creating standards for improvements in 
patient safety; and implementing safe practices in health care delivery systems.   
Two years later, the IOM released another report, Crossing the Quality Chasm: A 
New Health System for the 21
st
 Century (Institute of Medicine, 2001). This report stressed 
the importance of building our healthcare system around six areas: safety, effectiveness, 
patient-centeredness, timeliness, efficiency, and equity. The report also stressed the 
importance of changing the environment of healthcare to: 1) apply evidence to healthcare 
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delivery; 2) use information technology; 3) align payment policies with quality 
improvement; and 4) prepare the workforce. 
These IOM reports initiated focus on healthcare quality and patient safety that 
continues today. Several other reports by the IOM, Patient Safety: Achieving a New 
Standard of Care, Preventing Medication Errors: Quality Chasm Series, and Health IT 
and Patient Safety: Building Safer Systems for Better Care continued to emphasize 
quality improvement and patient safety in the U.S. healthcare system.  
Reinforcing the goals and recommendations of the IOM reports is the Triple Aim 
of healthcare: improving the care experience, improving population health, and reducing 
per capita healthcare costs (Berwick, Nolan, & Whittington, 2008). These three aims are 
interdependent; changes in pursuing one aim can impact the other aims. Though quality 
and patient safety are not explicitly named in the Triple Aim, improvements in each aim, 
without negatively impacting other aims, requires a focus on quality and patient safety. 
For example, to reduce the per capita healthcare costs without a decline in the patient care 
experience requires improvements in processes that reduce waste. Strategies to reducing 
waste address: failures of care delivery, failures of care coordination, overtreatment, 
administrative complexity, pricing failures, and fraud and abuse (Berwick & Hackbarth, 
2012). Eliminating waste in any of these categories results in an increase in quality and/or 
patient safety.  
For nearly two decades, the U.S. healthcare system has continued to focus on both 
quality and patient safety. As advances in science and technology continue at exponential 
rates, it becomes impossible to comprehend and retain this information (Cobb, 2004; 
Institute of Medicine, 2001). Additionally, between the large patient populations for 
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which each physician cares and the ever-increasing number of available prescription 
drugs, providers are unable to remember all drugs each patient is taking and what 
potential drug-drug or drug-allergy interactions for which each patient could be at risk. 
Considering that information plays a key role in the reduction of errors and it is crucial 
for clinicians to stay current with advances, the potential role of health information 
technology holds much promise (Cobb, 2004; Einbinder & Bates, 2007).  
Patient Safety – Adverse Drug Events 
Definitions 
 Various terms describe specific types of medication errors; commonly used terms 
are defined and referenced in Table 2.1. A visual representation of the relationship 
between the terms is also provided below in Figure 2.1.  Medication errors and adverse 
drug events (ADEs) can have multiple sources that range from practice, products, 
procedures, and systems (Institute of Medicine, 2007). In the universe of all prescriptions, 
half of prescriptions are reported to have some type of error; most of which do not result 
in harm (Lisby, Nielsen, & Mainz, 2005; “Suggested definitions and relationships among 
medication misadventures, medication errors, adverse drug events, and adverse drug 
reactions.,” 1998). ADEs, defined as injuries that are the result of medication, fall into 
two categories: nonpreventable ADEs (also referred to as adverse drug reactions in the 
health services research literature) and preventable ADEs. Preventable ADEs may or may 
not result in harm. Preventable ADEs can be prevented through various error reducing 
practices. Some preventable ADEs and nonpreventable ADEs have serious consequences 
(“Suggested definitions and relationships among medication misadventures, medication 
errors, adverse drug events, and adverse drug reactions.,” 1998). An example of a 
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preventable ADE would be an incorrect medication dosage that leads to patient harm or 
injury. Nonpreventable ADEs are unanticipated drug effects. An example of a 
nonpreventable ADE would be an allergic reaction in a patient not known to have an 
allergy (Institute of Medicine, 2007).  
Table 2.1 Key terms utilized in healthcare medication error literature  
Terms Source Definition 
Medication 
Error 
(D. Bates, Cullen, & 
Laird, 1995) 




for Medication Error 
Reporting and 
Prevention, 2014b)  
“any preventable event that may cause or 
lead to inappropriate medication use or 
patient harm while the medication is in the 
control of the health care professional, 





“an injury resulting from medical 
intervention related to a drug” 
(Cresswell, Fernando, 
McKinstry, & Sheikh, 
2007) 
“an unwanted occurrence after exposure to a 
drug that is not necessarily caused by the 
drug” 
(D. Bates et al., 1995) “any injury due to medication” 
Preventable 
Adverse Event  
(Institute of 
Medicine, 1999) 




referred to as 
Adverse Drug 
Reaction) 
(Cresswell et al., 
2007) 
“any undesirable effect of a drug beyond its 
anticipated therapeutic effects occurring 




Figure 2.1 Relationship between medication errors and adverse drug events  
ADEs are of particular public health importance because of the high numbers of 
Americans taking prescription drugs, particularly older Americans. Across 2007-2010, 
approximately 40% of Americans aged 65 years and over used five or more prescription 
drugs in the past 30 days; an increase from 28% during 1999-2002 (U.S. Food and Drug 
Administration, 2013b). The Food and Drug Administration Adverse Event Reporting 
System (FAERS) has seen a continued increase in the number of reported adverse events 
and serious patient outcomes in the past decade (U.S. Food and Drug Administration, 
2013a).  ADEs are seen in older adults nearly 7 times more often than among adults 
younger than 65 years (Lucado, Paez, & Elixhauser, 2011). These ADEs result in over 
half (53%) of all inpatient stays with a drug-related adverse outcome among this age 
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group (Lucado et al., 2011). In this patient population, ADEs are an important indicator 
of patient safety. These adverse events have been associated with an increase in the 
length of hospitalization, resource utilization, expense, and risk of mortality (Daniel S 
Budnitz et al., 2006; Classen, Pestotnik, Evans, Lloyd, & Burke, 1997; Field et al., 2005; 
Hug, Keohane, Seger, Yoon, & Bates, 2012). Recent estimates suggest that between 
100,000 to 200,000 older adults are hospitalized each year for ADEs (D S Budnitz, 
Shehab, Kegler, & Richards, 2007; Gabriel, Furukawa, & Vaidya, 2013).   
Estimates of ADEs 
Literature on ADE estimates focus on several settings: within hospitalization 
stays, emergency department visits, emergency department visits leading to 
hospitalization, and outpatient office visits. Between 1.4% to 41.4% of patients 
experience an ADE while hospitalized (Cano & Rozenfeld, 2009; Senst et al., 2001). 
However, ADEs are more likely to be present on admission than to originate during a 
hospital stay (Weiss, Elixhauser, Bae, & Encinosa, 2013). Approximately 12% of 
emergency department visits are estimated to be due to ADEs (Zed et al., 2008)(Yee, 
Hasson, & Schreiber, 2005). Only a small percentage (<1%) of drug-related emergency 
department visits are treat-and-release visits (Lucado et al., 2011). Of all hospital stays 
that were the result of an emergency department visit, it is estimated that between 2.4% 
and 9.0% are caused by ADEs (D. Bates et al., 1995; Daniel S Budnitz et al., 2005; 
Kaushal, Barker, & Bates, 2001; Leape et al., 1991; Lucado et al., 2011; Moore, 
Lecointre, Noblet, & Mabille, 1998; Senst et al., 2001; von Laue, Schwappach, & Koeck, 
2003). Senst et al. (2001) found that over three-fourths (76%) of ADE-related hospital 
admissions were preventable. The literature on outpatient visits due to ADEs is sparse; 
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the few studies conducted in this setting estimate that 5.0-5.5 per 100 person-years are 
due to ADEs (Gurwitz et al., 2003; Honigman et al., 2001). 
Potential Causes of ADEs 
 Several different factors contribute to the hospitalization of older adults for ADEs 
(Cresswell et al., 2007). The most cited potential causes include polypharmacy and/or 
polymedicine, traits of older adults that increase their susceptibility to ADEs, 
unnecessary or inappropriate use of medications, lack of communication between 
multiple providers, among others. 
The most cited reason is polypharmacy and/or polymedicine. Polypharmacy is 
defined as the “use of multiple medications and/or administration of more medication 
than are clinically indicated” (Parsons, Lapane, Kerse, & Hughes, 2011). Polymedicine is 
defined as the “increasing number of medications related to a similarly increasing number 
of medical problems” (Pham & Dickman, 2007). Both polypharmacy and polymedicine 
shed light on the increased number of medications taken by this age group and the 
potential for them to cause ADEs (Bourgeois, Shannon, Valim, & Mandl, 2010; Y.-C. 
Chen et al., 2014; Lattanzio et al., 2012; Malhotra, Karan, Pandhi, & Jain, 2001; ZA 
Marcum et al., 2012; Martínez-Cengotitabengoa, Besga, Fernández, Micó, & González-
Pinto, 2011; Olivier et al., 2009; Parsons et al., 2011; Roulet et al., 2014; Stuck et al., 
1994). One study, conducted by Nickel et al. (2013), estimates that each additional drug 
taken by an individual accounted for a 10% increase in probability of suffering from a 
drug-related problem. In addition to the increased use of pharmaceuticals in our country, 
the unique characteristics of the older population may contribute to their increased rate of 
ADE hospitalizations (Daniel S Budnitz et al., 2006; Salvi et al., 2012).  Older adults are 
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the most likely age group to require hospitalizations of any kind and their considerable 
use of pharmaceuticals lends them to an increased risk of ADEs (Bourgeois et al., 2010; 
Nickel et al., 2013). This population also tends to have multiple comorbidities, such as 
congestive heart failure, diabetes, and cancer, live in rural areas, and have a higher 
severity of illness; all of which increase the risk of ADEs (Salvi et al., 2012; Sikdar et al., 
2012). Steinman, Hanlon, Sloane, Boscardin & Schmader (2011) have shown that 
“geriatric conditions” alone, such as disability in at least one activity of daily living, mild 
or moderate dementia, incontinence, a recent fall, needing assistance with ambulation, 
malnourishment, depression, and prolonged bed rest, do not increase the risk of ADEs.  
Other researchers believe that unnecessary or inappropriate use of medications are 
the “true risk factor” for ADEs (Field, Gurwitz, Harrold, Rothschild, DeBellis, et al., 
2004; Parsons et al., 2011; Salvi et al., 2012; Stuck et al., 1994). Inappropriate or 
unnecessary use of medications, such as antibiotics, cardiovascular agents, anti-diabetic 
drugs, antiplatelet agents, and others, are commonly determined to be the cause of an 
ADE (D S Budnitz et al., 2007; Daniel S Budnitz et al., 2005; Daniel S Budnitz, 
Lovegrove, Shehab, & Richards, 2011; Cahir, Bennett, Teljeur, & Fahey, 2014; Capuano 
et al., 2009; Y.-C. Chen et al., 2014; Elixhauser & Owens, 2007; Field, Gurwitz, Harrold, 
Rothschild, DeBellis, et al., 2004; Olivier et al., 2009; Parsons et al., 2011; Shehab, Patel, 
Srinivasan, & Budnitz, 2008; Sikdar et al., 2012; Tangiisuran, Davies, Wright, & 
Rajkumar, 2012; Weiss et al., 2013). Most of these ADEs are preventable during the 
prescribing process (D. Bates et al., 1995). As the number of drug classes taken by a 
single individual increases, there is an increased risk of ADEs due to harmful drug 
interactions (Cahir et al., 2014; Hines & Murphy, 2011).  
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The lack of communication and coordination between healthcare providers is also 
a commonly cited risk factor of ADEs (Boockvar et al., 2009; Parsons et al., 2011). 
Green, Hawley, & Rask (2007) found that the number of prescribing physicians was an 
independent risk factor for self-reported ADEs.  Concurrent prescribing by multiple 
providers is a common practice among older adults and has been associated with higher 
rates of hospital admission (Jena, Goldman, Weaver, & Karaca-Mandic, 2014). The final 
few potential causes of ADEs include: non-adherence to medication regimens (Cahir et 
al., 2014; Malhotra et al., 2001; Parsons et al., 2011; Salvi et al., 2012), and the lack of 
drug knowledge dissemination (Leape et al., 1995). 
 With the high risk, multiple potential causes, and high cost of ADEs in the older 
patient population, it is essential to ensure effective prescribing habits are followed and 
ADEs are prevented (Willlams, 2002). Fortunately, the most preventable adverse events 
that have severe complications are more identifiable than less severe adverse events (D 
W Bates et al., 1994). Howard et al. (2007) used Reason's (1990) “Swiss cheese model” 
to demonstrate how system failures, active breakdowns, and proximal causes lead to 
many ADE hospitalization in ambulatory care patients.  
ADE Prevention 
Several methods have been proposed and utilized by healthcare professionals to 
detect and reduce ADEs, including explicit criteria for potentially inappropriate 
prescriptions for adults 65 years and older, incorporating pharmacist input into all aspects 
of medication management, improving communication between providers, conducting 
retrospective reviews, using computerized information systems and alerts, and educating 
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patients on the benefits of medication compliance and risks of polypharmacy (Garcia, 
2006). 
Many explicit criteria have been developed to improve medication management 
among the older patient population, including Beers criteria, Screening Tool of Older 
Persons’ Prescriptions (STOPP) and Screening Tool to Alert doctors to Right indicated 
Treatment (START) criteria, the Research on Adverse Drug Events and Reports 
(RADAR) Project, and the National Coordinating Council for Medication Error 
Reporting and Prevention (NCC MERP) (Garcia, 2006; “National Coordinating Council 
for Medication Error Reporting and Prevention,” 2014a; Pretorius, Gataric, Swedlund, & 
Miller, 2013). Beers criteria was initially created using the Delphi method for consensus 
on defining inappropriate medication use in nursing homes (Beers et al., 1991). This 
criteria was updated in 2003 to be applicable to all adults 65 years and older, regardless 
of living conditions (Fick et al., 2003). However, some studies have found that Beers 
criteria, though widely used, may not be enough to reduce the risk of ADEs (Page 2nd & 
Ruscin, 2006). STOPP and START were also created using the Delphi consensus 
technique, which resulted in 65 clinically significant criteria for STOPP and 22 evidence-
based prescribing indicators for START (Gallagher, Ryan, Byrne, Kennedy, & 
O’Mahony, 2008). The RADAR Project, funded by the National Heart, Lung, and Blood 
Institute, the National Cancer Institute, the American Cancer Society, and the Department 
of Veterans Affairs, supplements other national surveillance projects by identifying, 
evaluating, and disseminating information that describe serious adverse drug reactions to 
physicians (Bennett et al., 2005). The NCC MERP is an independent body comprised of 
27 national organizations that strive to increase the safe use of medications to increase the 
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awareness of medication errors through reporting, understanding, and preventing 
(“National Coordinating Council for Medication Error Reporting and Prevention,” 
2014a). Other criteria created for a similar purpose include: the Improved Prescribing in 
the Elderly Tool (IPET), the Prescribing Appropriateness Index (PAI), Zhan’s Criteria, 
the French Consensus Panel List, the Australian Prescribing Indicators Tool, the 
Norwegian General Practice (NORGEP) Criteria, the Medication Appropriateness Index 
(MAI), and the Assessment of Underutilization of Medication (AOU) Tool (O’Connor, 
Gallagher, & O’Mahony, 2012).  
 The second method utilized to detect and reduce ADEs is a provider-oriented and 
provider-led process. Involving all providers in shared decision making and 
individualizing prescribing decisions to patient specific characteristics, such as age, race, 
comorbidities, etc. has been shown to reduce ADEs (Pretorius et al., 2013). To ensure 
this method is effective, it is encouraged the pharmacist-led medication reviews occur 
(Cresswell et al., 2007; Gallagher, Barry, & O’Mahony, 2007; Garcia, 2006; Sorensen et 
al., 2004), educational outreach interventions are available to enhance professional 
behaviors (Cresswell et al., 2007), and providers communicate and coordinate medication 
management and care provision (Green et al., 2007). With 38.1% of Medicare Part D 
beneficiaries utilizing multiple pharmacies and 43% of older Americans being prescribed 
medications by more than one physician, medication reconciliation and communication 
among prescribers is essential to preventing medication errors (Barnsteiner, 2005; 
International Communications Research for the American Society of Health-System 
Pharmacists, 2001; Z Marcum, Driessen, Thorpe, Gellad, & Donohue, 2014). The 
inclusion of pharmacists in all stages of medication delivery has also been stressed by 
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several studies (Anderson, 2003; Fuji & Galt, 2008; Garcia, 2006). In fact, the Brigham 
and Women’s Hospital decreased ADE rates in the intensive care unit by 67% by 
including pharmacists in patient rounds (Leape et al., 1999).  
Bates & Gawande (2003) state three methods by which HIT functions, such as 
ADE alert systems, computer decision support systems (CDSS), and e-prescribing, can 
reduce errors: by preventing errors and adverse events, facilitating rapid response after an 
adverse event, and tracking and providing feedback about adverse events. Hwang, Lee, 
Koo, & Kim (2008) found that most ADEs and nearly all severe ADEs were identifiable, 
though ADE hospitalizations were not included in the definition of severe ADEs. D W 
Bates, Boyle, Vander Vliet, Schneider, & Leape (1995) also found that computerized 
physician order entry systems could prevent the majority of medication errors and ADEs. 
Computerized systems allow for increased access to patient and drug information at the 
point of care and have the capability for CDSS alerts that incorporate explicit criteria, 
such as those described previously (Beuscart et al., 2009; Garcia, 2006; Leape et al., 
1995; Nwulu, Nirantharakumar, Odesanya, McDowell, & Coleman, 2013; Pham & 
Dickman, 2007). CDSS and e-prescribing provide methods to prevent medication errors 
and ADEs through process simplification, system linkages, and patient-specific alert 
systems (D W Bates et al., 2001; Bell & Friedman, 2005). A single hospital was able to 
detect 26% of medication errors and prevent associated ADEs that could have resulted in 
1,226 days of hospitalization and $1.4 million (Anderson, Jay, Anderson, & Hunt, 2002). 
The Veterans Administration hospitals used HIT to reduce incorrectly administered 
medications from 1 in 20 to less than 1 in 100,000 ambulatory care prescriptions 
(President’s Information Technology Advisory Committee, 2004). Additionally, 
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INTERCheck, a computerized prescription support system developed in Northern Italy to 
aid in prescription management for elderly patients with multiple comorbidities, was 
associated with a decrease in potentially inappropriate medication prescriptions and 
potential drug-drug interactions in an Italian acute geriatric ward (Ghibelli et al., 2013). 
In several instances, these systems have also decreased pharmacy department costs, drug 
costs, severity-adjusted mortality rates, and non-missed-dose medication errors (D W 
Bates et al., 1999; Piontek et al., 2010).  
On the other hand, although e-prescribing software products have been said to be 
cost-effective and an added value for all practice sizes (Corley, 2003; Honigman et al., 
2001),  ADE detection algorithms are far from perfect. Continued enhancement for 
consideration of clinical priorities will increase their utility (Forster, Jennings, Chow, 
Leeder, & van Walraven, 2012; Rask et al., 2005).  
Computerized information systems can also be utilized retroactively. For 
example, a web tool called “ADE Scorecard” screens past hospitalizations extracted from 
an EHR and allows physicians to see ADE statistics within their department, useful rules, 
and review ADE cases through a comprehensive interface with de-identified records 
(Chazard, Băceanu, Ferret, & Ficheur, 2011). As stated previously, computerized systems 
only provide a tool for detecting and reducing ADEs (Anderson, 2003). The human 
factors perspective views errors in two ways: the person approach, which focuses on 
individuals, and the system approach, which concentrates on the conditions surrounding 
the individuals (Reason, 2000). Smetzer (1998) describes how three nurses were charged 
with negligent homicide for medication errors that resulted in the death of a newborn. 
While this incident did not involve a computerized system, it illustrates how 
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approximately 50 system failures, such as staff inexperience, poor documentation, 
unclear manufacturer labeling, and no staff education before dispensing nonformulary 
drugs,  resulted in a devastating tragedy. Without process change and a systems 
perspective, computerized information systems could result in similar unintended 
negative consequences (Anderson et al., 2002; Greene, 2006). 
These major strategies are generally complemented with patient education to 
encourage symptom reports (Garcia, 2006) or retroactive strategies, such as root cause 
analysis, failure mode effect and criticality analysis, and human factor engineering, to 
determine human, organization, and cognitive factors that influence the rate of ADEs 
(Beuscart et al., 2009; Gertler, Coralic, López, Stein, & Sarkar, 2014; Schneider, 2002; 
Williams & Talley, 1994). The use of multiple strategies, such as an IT intervention in 
conjunction with inter-professional communication, and a systems approach to reducing 
ADEs have been encouraged in the literature by many (Field, Gurwitz, Harrold, 
Rothschild, Debellis, et al., 2004; Lainer, Mann, & Sönnichsen, 2013; Reason, 2000; 
Salvi et al., 2012; Schaubhut & Jones, 2000; Silverman et al., 2003). 
Intersection of Patient Safety and Health Information Technology 
Using the ten rules provided by the IOM’s Crossing the Quality Chasm report as a 
backbone, Kilbridge (2002) describes the potential of health information technology 
(HIT) to aid in meeting quality standards with illustrative case study examples. The four 
main principles of healthcare that are described include patient empowerment, reliability 
and safety, care relationships beyond the encounter, and public accountability for quality. 
Technologies with the ability to aid in the improvement of healthcare quality include 
personal health records, electronic medical records, pre-visit intakes, health information 
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exchange, population management tools, electronic messaging, online scheduling, 
computer-assisted telephone triage and assistance, and publicly available provider 
performance data. 
HIT offers the potential to reduce risk by assisting in decisions, providing 
feedback on performance and steamlining care (David W Bates & Gawande, 2003; 
Myers & Shannon, 2012). Key features offered by HIT include improved 
communication, especially between clinicians (David W Bates & Gawande, 2003; 
Huckvale et al., 2010; Rao, Brammer, McKethan, & Buntin, 2012); providing access to 
information at the point-of-care (David W Bates & Gawande, 2003; Huckvale et al., 
2010; Rao et al., 2012); combating medication errors (David W Bates & Gawande, 2003; 
Huckvale et al., 2010; van Doormaal et al., 2009); support in evidence-based decision 
making (David W Bates & Gawande, 2003; Huckvale et al., 2010); and improved 
medication safety through rapid response and tracking of adverse events  (David W Bates 
& Gawande, 2003; Huckvale et al., 2010; Jha, Kuperman, Rittenberg, Teich, & Bates, 
2001). 
A systematic review conducted by Chaudhry et al. (2006) on the impact of HIT 
on quality, efficiency, and costs of health care had several promising findings. The 
review found improvements in quality through the use of HIT to be attributable to an 
increase in adherence to guidelines, enhanced disease surveillance, and decrease in 
medication errors. Efficiency was also improved through a decrease in the utilization of 
care. They also reported only limited data on cost savings, time utilization, 
interoperability, and consumer use of HIT. A major limitation to this review was the 
generalizability of these findings; as many studies were conducted in single organizations 
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or healthcare systems. Another review conducted by Buntin, Burke, Hoaglin, & 
Blumenthal (2011) has found mostly positive and mixed-positive improvements in access 
to care, preventive care, care processes, patient satisfaction, patient safety, provider 
satisfaction, effectiveness of care, and efficiency of care. However, other reviews have 
stated that more robust evaluations of HITs are necessary to determine the true impact on 
quality and safety (Black et al., 2011; Parente & McCullough, 2009).  
 While there are many types of HITs available to aid in the quality and patient 
safety initiatives of the U.S. healthcare system, computerized provider order entry 
(CPOE), health information exchange (HIE), and clinical decision support systems 
(CDSS) have the greatest potential for patient safety (J. C. H. Chen, Dolan, & Lin, 2004; 
Kaelber & Bates, 2007; Lilja & Egebart, 2011; McGregor et al., 2006). CDSSs are 
designed to aid healthcare provider clinical decision making; software algorithms provide 
patient-specific recommendations to practitioners. These systems have shown improved 
practitioner performance and adherence to evidence-based practice guidelines (Ahmed, 
Tamblyn, & Winslade, 2014; A. X. Garg et al., 2005; Roy et al., 2009; Toth-Pal, Wårdh, 
Strender, & Nilsson, 2008). CPOE systems, which can be implemented with a CDSS 
feature, are electronic applications that allow for direct entry of orders for laboratory 
tests, procedures, radiology imaging, and medications (Hook & Cusack, 2008). CPOE 
has also been shown to have significant improvements in patient safety initiatives, 
including medication safety and reduction in adverse drug events (Devine et al., 2010; 
Eslami, Abu-Hanna, & de Keizer, 2007; A. X. Garg et al., 2005; Shamliyan, Duval, Du, 
& Kane, 2008; Wolfstadt et al., 2008). Lastly, HIE provides healthcare providers secure, 
electronic access to a patient’s medical information. With a complete medical history 
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available at the point-of-care, HIE is expected to reduce medication errors, improve 
diagnoses, decrease duplicate testing, in addition to other benefits (Frisse et al., 2012; 
Jones, Friedburg, & Schneider, 2011; Office of the National Coordinator for Health 
Information Technology, n.d.-b).   
Electronic Prescribing (e-prescribing) in the U.S. 
To ensure that HIE is possible and a societal benefit can be realized, one of the 
key components of the Office of the National Coordinator for Health Information 
Technology (ONC) strategic framework included interoperability or the ability of 
healthcare systems to work together (Brailer, 2005; Office of the National Coordinator 
for Health Information Technology, n.d.-a). Interoperability benefits are spread across 
many different stakeholders (Brailer, 2005). Specifically, improvements can be seen in 
medication, laboratory, radiology, and public health information processing; 
communication among providers; and communication between patients and providers 
(Kaelber & Bates, 2007).  
Federal Legislation & Incentive Programs 
 In an effort to accelerate adoption of HITs in the U.S., federal legislation and 
incentive programs have been established. The Medicare Prescription Drug, 
Improvement, and Modernization Act (MMA) of 2003 included a provision to increase 
the adoption of electronic prescribing (e-prescribing). The potential to improve accuracy 
and efficiency of medication use in Medicare beneficiaries was a leading factor in the 
MMA requirement for Part D plans to support a voluntary e-prescribing program (Bell & 
Friedman, 2005). Additionally, the National Committee on Vital and Health Statistics 
was to aid in the initial development standards for e-prescribing.  
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 In April 2004, former President Bush set a goal for the majority of Americans to 
use electronic health records (EHRs) by the year 2014. Additionally, the President’s 
Information Technology Advisory Committee (PITAC) published a report titled 
Revolutionizing Health Care Through Information Technology. This report contained a 
framework for a healthcare information infrastructure, which centered around 4 elements: 
1) EHRs for all Americans; 2) computer-assisted CDSS to enhance evidence-based 
decision making at the point-of-care; 3) CPOE; and 4) electronic HIE that is secure, 
private and interoperable (President’s Information Technology Advisory Committee, 
2004). In 2005, the Centers for Medicare and Medicaid Services (CMS) published a final 
rule on standards for providers and pharmacies using e-prescribing.  
 In November 2008, the CMS introduced the e-prescribing (eRx) Incentive 
Program, as part of the Medicare Improvements for Patients and Providers Act of 2008 
(MIPPA). This program offered incentives to physicians and other eligible professionals 
who met certain eligibility requirements. Beginning January 2009, CMS began offering 
e-prescribe payment incentives to eligible providers of up to 2% of their Medicare Part B 
charges for services. In 2012, a total of $334,331,216 in eRx Incentive Program payments 
were made to 227,447 eligible professionals and 55,015 practices (Centers for Medicare 
and Medicaid Services, 2014a). Between the years of 2010 and 2012, a total of 
$891,275,859 were paid to eligible professionals and practices through the eRx Incentive 
Program (Centers for Medicare and Medicaid Services, 2014a).   
 President Obama renewed the commitment to EHRs set by former President Bush 
by allocating funds for the CMS EHR Incentive Program through the Health Information 
Technology for Economic and Clinical Health (HITECH) Act in the American Recovery 
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and Reinvestment Act of 2009 (ARRA). The CMS EHR Incentive Program is guided by 
“Meaningful Use” criteria, a program that parallels the eRx Incentive Program. Several 
objectives of the Meaningful Use criteria are pertinent to medication management: the 
ability to generate and transmit permissible prescriptions electronically and use CPOE for 
medication orders directly entered by any licensed healthcare professional who can enter 
orders into the medical record per state, local, and professional guidelines (Blumenthal & 
Tavenner, 2010). Several other guidelines, such as implementing drug-drug and drug-
allergy interaction checks, maintaining active medication lists, maintaining active 
medication allergy lists, and implementing drug-formulary checks, were incorporated 
into clinical decision support and summary of care document measures and are no longer 
separate objectives in Stage 2 Meaningful Use criteria (Centers for Medicare and 
Medicaid Services, 2012). The CMS EHR Incentive Program to-date has awarded 
$21,612,234,517 to eligible Medicare and Medicaid professionals and hospitals (Centers 
for Medicare and Medicaid Services, 2014b).  
The HITECH Act also established the ONC to coordinate national efforts on 
health information technology. A key component to the strategic framework of the ONC 
was interoperability, which allows for the providers to communicate with one another 
(Kuperman, 2011). The final big portion of the HITECH Act was the State Health 
Information Exchange Cooperative Agreement Program , which awarded $547,703,438 
to 56 states and eligible territories through the ONC (Office of the National Coordinator 
for Health Information Technology, 2014c). This program was created to assist in 
building the capacity for exchanging health information at the state-, regional-, and 
24 
 
national- level. This program included, but was not limited to, the implementation of 
infrastructure for e-prescribing.  
Adoption of HITs and e-Prescribing 
It is important to note the distinction between HIT and e-prescribing prior to 
discussing the adoption rates of each. HIT, as used in this study, refers to a broad concept 
that can include technologies with many different functions such as EHRs or personal 
health records. E-prescribing, on the other hand, refers to a specific function or 
subfunction that can be utilized in a standalone system, as part of a CPOE system, or can 
be incorporated into an EHR system.  
Despite the economic incentives provided by the federal government through the 
programs documented in the preceding section, the adoption of HIT systems has 
historically been low (Karsh, Weinger, Abbott, & Wears, 2010).  In 2006, the use of HIT 
features ranged between 10-50% (Brooks, Menachemi, Burke, & Clawson, 2005; Figge, 
2009; Furukawa, Raghu, Spaulding, & Vinze, 2008; Poon et al., 2006). However, 
significant differences in the adoption of various features have emerged and currently 
hospitals have shown greater adoption rates than physician practices (Furukawa et al., 
2008; Pallin, Sullivan, Kaushal, & Camargo, 2010). The least adopted electronic 
capabilities among physicians include patient engagement, structured lab results, and 
immunization registry reporting (Office of the National Coordinator for Health 
Information Technology, 2014b).  
Despite low rates of adoption of most HITs, the rate of medication-related 
computerized capabilities has increased dramatically among inpatient and ambulatory 
care physicians during the past decade. These significant increases in adoption rates may 
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be due in part to the early focus on e-prescribing and continued federal incentives, as 
discussed previously. In 2005, Massachusetts reported 38% of their emergency 
departments had medication ordering capabilities (Pallin et al., 2010). Between the years 
of 2009-2013 there was a significant increase in use of CPOE for medication, drug 
interaction checks, and CDSS (J. King, Patel, & Furukawa, 2012). Furthermore, the rates 
of e-prescribing have nearly doubled from 33% to 73% between 2009-2012 (J. King et 
al., 2012). Others report the percentage of physicians e-prescribing via an EHR increased 
from less than 10%  in 2008 to over 65% in 2013 (Hufstader, Swain, & Furukawa, 2012; 
Office of the National Coordinator for Health Information Technology, 2014a; 
Surescripts, 2012).  
 Barriers to e-Prescribing  
E-prescribing, like many other HIT functions, was initially slow to be adopted due 
to financial barriers, legal barriers, lack of standards, and cultural barriers (David W 
Bates & Gawande, 2003; Buntin et al., 2011; J. C. H. Chen et al., 2004; Furukawa et al., 
2008). Other initial obstacles to e-prescribing adoption included the financial cost of 
implementation, which ranges from $500-$2,500 per year for a stand-alone system to 
$25,000-$45,000 per physician for a comprehensive EHR system (Bell & Friedman, 
2005; Figge, 2009; Furukawa et al., 2008; Jariwala, Holmes, Banahan 3rd, & McCaffrey 
3rd, 2013; Lundy, Anderson, & Valentine, 2009); incompatibility between different 
vendor systems (Bell & Friedman, 2005) (Balfour 3rd et al., 2009; Bell & Friedman, 
2005); confusion about functionality (Bell & Friedman, 2005); limited connectivity 
(Lundy et al., 2009); resistance to change (Jariwala et al., 2013; Lundy et al., 2009); and 
the prohibition on e-prescribing for controlled substances (Lundy et al., 2009).  
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The implementation of e-prescribing systems is not a simple “plug and play” 
system; it requires not just the technology itself (Karsh et al., 2010), but also the 
resources to ensure that system is tailored to the needs of the organization (Damberg et 
al., 2009; Nanji et al., 2011). The true value of the technology is how it is utilized by the 
individuals and organizations (Prince & Herrin, 2007). Several organizational changes 
need to be made prior to the implementation of any new technology (Menachemi, Burke, 
& Brooks, 2004). These changes include: workflow redesign that includes rethinking 
employee roles and responsibilities (Crosson et al., 2011; Ford, Huerta, Thompson, & 
Patry, 2011), a strategic importance placed on information technology (Menachemi et al., 
2004), a commitment from staff and upper management (Damberg et al., 2009; Prince & 
Herrin, 2007; Shah et al., 2006), and the continued involvement and enthusiasm of 
organizational leadership (Menachemi et al., 2004). The implementation of any 
technology requires persistence. If organization and “human” factor changes are not 
addressed, this could lead to an increase in medication errors (Damberg et al., 2009; 
Nanji et al., 2011). 
Benefits & Unintended Consequences of e-Prescribing 
 From a communication and safety standpoint, e-prescribing results in 
prescriptions that are clean and free of ambiguities (Figge, 2009), it improves patient 
safety and eliminates errors (Figge, 2009), and decreases the number of emergency 
department visits and medication-related hospitalizations (Weingart et al., 2009). 
Providers also report patient safety benefits, though they have not perceived the enhanced 
benefits that were expected (Wang et al., 2009). Providers are able to make better 
medication choices, without a reduction in the time spent with patients, which has 
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resulted in a decrease in medication spending for organizations and states (Fischer et al., 
2008; Weingart et al., 2009; Westbrook, Li, Georgiou, Paoloni, & Cullen, 2013). A 
further discussion on the potential of e-prescribing to decrease adverse drug events is 
discussed further in the adverse drug event section on page 29.  
Though the benefits of e-prescribing are widespread in the literature, unintended 
consequences have also been cited. One of the stated benefits of CDSS, a feature 
included in many CPOE systems for medications, is that it provides alerts for 
inappropriate use, drug-drug interactions, drug-allergy interactions and much more. 
However, over-alerting has led to a phenomenon called “alert fatigue,” where providers 
have decreased sensitivity to alerts leading to overrides due to the unspecific nature of the 
alerts (Ammenwerth, Hackl, Riedmann, & Jung, 2011; Beuscart et al., 2009). 
Technology-induced errors, discrepancies between structured and free-text fields, and 
missing or erroneous data which results in poor decisions are all additional unintended 
consequences of HIT (Borycki, 2013; Carvalho, Borycki, & Kushniruk, 2009; Palchuk et 
al., 2010; Sittig & Singh, 2011). Many of these errors will diminish as software products 
are engineered with safe user interfaces (Magrabi, Ong, Runciman, & Coiera, 2011). 
These updates should result in decreased confusion of medicine names, poor design of 
screens, and order entry errors (Ash et al., 2007; Cheung et al., 2014). Organizational 
process changes that are required for the successful implementation of any technology, 
such as workflow redesign and interpersonal relations, will require continuous 
monitoring, as will reimplementation of systems for upgrades and replacement systems 
(Ash et al., 2007). 
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 As policy initiatives and payment restructuring continue, the electronic exchange 
of health information and the implementation of e-prescribing will continue to accelerate 
(Furukawa, Patel, Charles, Swain, & Mostashari, 2013). As the adoption of e-prescribing 
rises, there is an increasing need to study the impact these technologies are having on the 
patient safety outcomes, such as medication errors and adverse drug events, in our 
healthcare system.  
Previous Research 
 The literature on the impact of HITs, including CPOE, CDSS, and e-prescribing 
on ADEs is sparse; Table 2.2 provides a comparison of these studies. Studies that 1) only 
examined the ADE detection abilities of HITs; 2) were computer simulations; 3) only 
examined the impact on possible/potential, not actual, ADEs; and 4) were systematic 
reviews were excluded from the comparison. Of the studies meeting the search criteria, 5 
observed a significant reduction in ADEs after the implementation of a HIT, 1 detected a 
reduction in harmful ADEs but no difference in all ADEs, and 8 observed no statistically 
significant difference due to HIT.  Studies examining the impact of HIT on ADEs were 
typically conducted within institutions and lacked external validity. Therefore, the 
proposed study for this dissertation innovates by providing a population-based approach 








Table 2.2 Comparison of studies examining the impact of health information technology on adverse drug events 
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 The use of theory is an essential, but underutilized element of research studies 
(Colquhoun et al., 2013).  This dissertation research will be grounded in a combination of 
several theories including: Berwick's (2003) application of Roger’s classic diffusion of 
innovation theory to the healthcare industry and Ancker, Kern, Abramson, & Kaushal's 
(2012) Triangle Model adaptation of Donabedian's (1988) structure-process-outcome 
model to evaluate the impact of health information technology on quality and safety. 
Each component of the new theoretical framework, which expands upon the Triangle 
Model, is illustrated in Figure 2.2 and described below.  
While the Triangle Model lends itself to evaluating the impact of HIT within an 
organization, this new theoretical framework provides a systems’ approach on describing 
the impact of HIT on healthcare outcomes. The new theoretical framework also provides 
a detailed explanation of each major element of the Triangle Model, using Berwick 
(2003) and Rogers (1995). The four structural elements: technology, provider, 
organization, and patient population from the Triangle Model are used as the backbone of 
the framework. The three processes are: the technology usage by providers; the 
implementation of technology by the organization; and the organizational factors that 
impact providers. The outcomes on the healthcare system (referred to as consequences in 



























 According to Rogers (1995), five key features--relative advantage, compatibility, 
complexity, trialability, and observability--are the most influential in determining the 
perception of a new technology or innovation. The first feature, relative advantage or 
perceived benefit, is one of the most powerful properties of innovation adoption. The 
majority of individuals adopt innovations when they are easy to understand and the 
benefits outweigh the risks. The second feature, compatibility, refers to the level at which 
the innovation aligns with the values, beliefs, and needs of the individual. For example, 
EHRs are typically designed to meet the needs of large urban hospitals. The same system 
would not be compatible with the values and needs of a small rural hospital, which cares 
for an entirely different patient population. The complexity or adaptability of an 
innovation also impacts adoption. If an innovation cannot be simplified or modified for 
specific use, the rate of diffusion is diminished. Lastly, having the ability to test 
(trialability) and see the innovation used by others (observability) can be used to predict 
adoption. These five perceptions of innovations can be utilized to determine the whether 
an innovation or technology will be adopted. When adoption curves, typically S-shaped, 
reach between 15% and 20% the innovation gains momentum and is adopted at an 
increasing rate.  
Adopter / Provider 
 Specific characteristics of the adopter, or the healthcare provider, are also 
associated with the rate of spread of a technology. Using the classic statistical bell curve, 
adopters are split into 5 different groups: innovators, early adopters, early majority, late 
majority, and laggards. The fastest adopting group, the innovators, occupies the first 
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2.5% of the bell curve. These individuals tend to be willing to take risks, have the 
financial means to take the risk, and are in close contact with scientific research and other 
innovators (Rogers, 1995). In healthcare, physician innovators tend to be thought of as 
“mavericks or may appear to be heavily invested personally in a specialized topic” 
(Berwick, 2003). The next group, the early adopters, is the next 13.5% of the bell curve. 
They are similar to innovators, but they are more discrete in their choice of adoptions and 
are seen as opinion leaders among their peers (Rogers, 1995). Within the healthcare 
industry, these adopters are generally elected leaders or clinical group representatives 
(Berwick, 2003). The next 34% of the bell curve is occupied by the early majority, who 
are in average social status, are risk averse, and look to others to determine their adoption 
choices (Rogers, 1995). Physicians in the early majority tend to adopt innovations based 
on their immediate needs (Berwick, 2003). The late majority, the second 34% of the bell 
curve, is highly skeptical and adopts long after their peers (Rogers, 1995).  The final 
groups, the laggards, are the final 16% of the adoption curve. They are typically 
“traditionalists” and only make changes when absolutely necessary (Rogers, 1995). 
Organization / Health System  
 The final set of factors that influence the rate of adoption of an innovation are 
contextual or managerial factors of an organization, such as mission, resources, and 
policies. The culture within an organization determines whether providers are more or 
less likely to adopt an innovation or technology. If an organization provides praise and 
encourages innovation, providers will be more likely to try novel ideas, while 
organizations that are traditionalists and discourage innovators are less likely to see 
change. Rogers (1995) discusses three types of leadership styles that impact the rate of 
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adoption or spread within an organization, called innovation-decisions: optional, 
collective, authority. Optional innovation-decisions are made independently by 
individuals, collective innovation-decisions are made via a consensus within an 
organization and all members of the organization are required to follow, and authority 
innovation-decisions are decisions made by a few powerful members of an organization 
and impact the entire organization. The adoption of technology within a healthcare 
organization is generally a collective or authority decision, depending on the size and 
organizational structure. However, single- or small group- practices make optional 
decisions, though they may be influenced by the norms of healthcare and the input of 
other providers.  
Patient 
 Central to the entire adoption process are patients. The patient population that a 
healthcare organization serves impacts the outcomes or consequences of technological 
adoption. The American population, in general, believes that HIT is an effective means of 
improving the quality and safety of health care (Gaylin, Moiduddin, Mohamoud, 
Lundeen, & Kelly, 2011). Studies have shown that HIT provides the means to increase 
continuity of care (Gentles, Lokker, & McKibbon, 2010), improve communication with 
patients (Gentles et al., 2010), and incorporate patient preferences to provide patient-
centered care (Montague & Asan, 2012). While some studies show an increase in patient 
satisfaction due to HIT (Nash et al., 2010; Restuccia, Cohen, Horwitt, & Shwartz, 2012; 
Roham, Gabrielyan, & Archer, 2012; Vest & Miller, 2011), others show no 
improvements (Rozenblum et al., 2013). To validly and appropriately compare different 
organizations requires adjustment for the served patient populations. Risk adjustment 
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should be considered for the variables including, but not limited to: case-mix, 
comorbidities, health literacy, patient engagement, race, income, and age.  
Processes 
 The processes established between the four main structural elements of the 
Triangle Model include: provider-technology, organization-provider, and organization-
technology (Ancker et al., 2012). Each of these processes has the potential to affect the 
outcomes of the healthcare organization. The proper use of the technology by the 
provider can impact whether positive expected outcomes are achieved. It is important to 
measure the provider-technology processes through measures such as: usability and 
actual use of features, integration into workflow, training effectiveness, and perceived 
usefulness.  The second process, describes the impact that organizational-level decisions 
support use of the technology. This includes factors such as: implementation, user 
training, resource allocation, and technical support. Proper support provided at the 
organizational level strongly impacts the level of satisfaction at the provider level 
(DeLone & McLean, 2003). Lastly, the policies and culture of an organization directly 
impact the activities of a provider, which in turn impact the outcomes of the healthcare 
system.  
Consequences / Outcomes 
 According to Rogers (1995) consequences are the least studied element of the 
diffusion of innovations model. The model classifies consequences as desirable or 
undesirable; direct or indirect; and anticipated or unanticipated. The directness of the 
consequences is based on whether the changes that are seen are immediate responses to 
an innovation. Whether a consequence is anticipated or not depends on the whether the 
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changes seen are recognized and intended. Consequences are also referred to as outcomes 
in other models, such as the Triangle Model (Ancker et al., 2012).    
Additional Factors 
 The adoption of technology and spread through society is measured over time, 
which is one of the final two factors that are described through the diffusion of 
innovations theory. Lastly, as the process of sharing ideas through communication 
channels increases, the innovation spreads and the rate of adoption increases.  
Study Design & Limitations of Previous Research 
 Studies in Table  depict the literature available on the impact of HITs on ADEs. 
Generalizability was a major limitation of every currently available study (Black et al., 
2011; Chaudhry et al., 2006). Furthermore, the majority of studies were conducted in a 
hospital setting and were determining the rate of ADEs occurring within a hospital stay. 
No studies were found that 1) examined the impact of HIT use in ambulatory settings on 
ADE hospitalizations; or 2) provided a population-based approach to the research 
question. The proposed study provides a population-based approach that aligns with one 
of the three Triple Aims discussed previously, as well as examining the impact of the 
ONC call for interoperability.  
 Of the three dimensions of health information users, as described in the 2001 
report by the National Committee on Vital and Health Statistics, the population health 
dimension allows for analysis of health system infrastructure (National Committee on 
Vital and Health Statistics, 2001). Ecological studies are appealing in health services 
research because the focus is on organizations or systems, rather than individual patients 
(Saunders & Abel, 2014). The principal example of ecological studies in health services 
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research is the use of ambulatory care sensitive condition admission rates as a measure of 
primary care service availability and quality (Brown et al., 2001; A. Garg, Probst, Sease, 
& Samuels, 2003). Previous health services researchers have also conducted county-level 
analyses to determine the association between food environments and health outcomes 
(Ahern, Brown, & Dukas, 2011), urban sprawl and cancer mortality (Berrigan, 
Tatalovich, Pickle, Ewing, & Ballard-Barbash, 2014), and availability of pediatric 
intensive care units to child death from trauma (Odetola, Miller, Davis, & Bratton, 2005). 
Each of these studies was designed to allow for a systems perspective in the interpretation 
of their findings. Similarly, the prevention of ADEs requires a systems perspective 
(Anderson et al., 2002). 
 It is important to note that hospital and ambulatory patient safety are different in 
the nature of errors, the patient-provider relationship; and organizational issues that each 
face (Wachter, 2006). While providers in the ambulatory setting stress the importance of 
communication and medication adherence in their offices, hospitals do not have intimate 
relationships with their patients (Wachter, 2006). Additionally, hospitals are visited by 
regulators, such as the Joint Commission, to ensure best practices are followed and a 
minimum standard of care is offered. Ambulatory offices do not have similar 
requirements (Wachter, 2006). Determining the impact of HIT on ADEs in a hospital 
setting does not allow for extrapolation to ambulatory care settings.  
 Given these limitations of previous research, the current study will determine the 
association of e-prescribing (technology) with hospitalizations for ADEs (consequence) 
at a population-level. It will take a multi-county approach to determine the population 
impact the adoption of technologies can have on healthcare outcomes. For the purposes 
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of this study, the term ADE will refer to the combination of nonpreventable and 
preventable ADEs. The distinction based on preventability of ADEs is not possible using 
this dissertation research datasets. Additionally, only ADEs that result in hospitalizations 
will be examined, as these events reflect the appropriateness of ambulatory prescribing 
(Thürmann, 2003). Considering that the rate of adoption and use of most HITs remains 
relatively low, minimum population-level impacts have been observed. Given that e-
prescribing can be viewed as an entry-level system compared to comprehensive HITs, 
such as electronic health records (EHRs), it is hoped that the findings of this study can 
provide a baseline on the impact of HIT adoption throughout the nation (Bell & 
Friedman, 2005). 
The specific aims and respective hypotheses of the study are: 
Aim 1.  Determine the relationship between the percentage of physicians in a county 
using electronic prescribing (e-prescribing) and county-level rates of ADE 
hospitalizations among patients 65 years and older.  
Hypothesis: High proportions of e-prescribing physicians will negatively correlate 
with the rates of ADE hospitalizations among patients 65 years and older.  
Aim 2. Determine the association between 2008-2011 change in percentage of physicians 
using electronic prescribing (e-prescribing) and change in county-level rates of ADE 
hospitalizations among patients 65 years and older. 
Hypothesis: As the rate of e-prescribing has increased from 2008 to 2011, the rate 





The study provided a multi-state perspective on the association between e-
prescribing and the frequency of hospitalizations for older Americans (age 65 years and 
older) due to ADEs. The specific aims and corresponding hypotheses of this study were: 
Aim 1. Determine the relationship between the percentage of physicians in a county using 
e-prescribing and county-level rates of ADE hospitalizations among patients 65 years and 
older.  
Hypothesis 1. It was hypothesized that high proportions of e-prescribing 
physicians will correlate negatively with the rates of ADE hospitalizations among 
patients 65 years and older. 
Aim 2. Determine the association between 2008-2011 change in percentage of physicians 
using e-prescribing and change in county-level rates of ADE hospitalizations among 
patients 65 years and older.  
Hypothesis 2. It was hypothesized that as the rate of e-prescribing had increased 
from 2008 to 2011, the rate of ADE hospitalizations had decreased at the county 
level. 
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Institutional Review Board (IRB) 
 Approval from the University of South Carolina IRB was granted on July 24
th
, 
2014. The study was categorized as “exemption status,” as de-identified secondary data 
was utilized for this study.  
Data Sources 
 This study utilized three datasets: the Healthcare Cost and Utilization Project 
(HCUP) State Inpatient Databases (SID) of 6 states for the years 2008 and 2011, the 
Office of the National Coordinator (ONC) Health IT Dashboard – Health IT Adoption 
and Use dataset, and the Health Resources and Services Administration (HRSA) Area 
Health Resource File (AHRF). The HCUP SID was used to determine the outcome of 
interest, the aggregate rate of ADEs in the older adult population, based on primary 
diagnosis codes. Data from the ONC Health IT Dashboard – Health IT Adoption and Use 
dataset was utilized to determine the independent variable, percentage of physicians e-
prescribing in each county. The linked HCUP SID and ONC dataset file, were merged 
with the AHRF to obtain county-level control variables.   
 The 2008 and 2011 HCUP SID provides a discharge record for all inpatient 
hospital stays in a given state (HCUP Databases, 2014). Currently, 47 states participate in 
HCUP SID; representing about 97% of all U.S. community hospital discharges. Variables 
included in the dataset include, but are not limited to: diagnoses and procedures, 
admission and discharge status, length of hospital stay, expected payment source, total 
charges, and patient demographic characteristics.  This dataset was merged with the ONC 
dataset using state and county Federal Information Processing Standards (FIPS) codes.  
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The ONC Health IT Dashboard is an open government project that provides the 
percentage of e-prescribers that are prescribing on the Surescripts network, by county 
from 2008-2013 (Office of the National Coordinator for Health Information Technology, 
2014). Surescripts is the country’s largest electronic prescribing network, it is used by 
approximately 95% of U.S. community pharmacies, excluding closed systems such as 
Kaiser Permanente (“Surescripts,” 2014c). Medication history functionalities via the 
Surescripts network allow for risk management of ADEs, drug-drug interactions, and 
drug-allergy interactions (Surescripts, 2014b). The top 10 EMR vendors of certified 
EMRs for healthcare professionals are utilized by 2 out of 3 healthcare professionals and 
have patient medication history functionalities via the Surescripts network (Surescripts, 
2014a). Of the non-dominant EMR vendors, 65.1% (450 of the 691 vendors) have 
medication history functionalities enabled (Surescripts, 2014a).   
Lastly, the AHRF provides an extensive county-level database drawn from more 
than 50 sources, including the American Hospital Association, American Medical 
Association, Centers for Medicare and Medicaid Services, the National Center for Health 
Statistics, the U.S. Census Bureau, and many more (Health Resources and Services 
Administration, 2014).  
Study Sample  
 This research examined ADE hospitalization rates across 6 states, chosen because 
these states include a “present on admission” (POA) indicator when providing 
information to the HCUP SID (Healthcare Cost and Utilization Project, 2008). The POA 
indicator indicated that the ADE occurred in the community and thus was likely to be 
associated with outpatient provider prescriptions, rather than occurring during a 
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hospitalization. Evidence on the reliability and usefulness of the POA indicator 
demonstrates that it increases the precision of ICD-9 codes (Coffey, Milenkovic, & 
Andrews, 2006; Kassed, Kowlessar, Pfunter, Parlato, & Andrews, 2011). Studied states 
included Arizona, Florida, Maryland, Michigan, New Jersey, and Washington. Together, 
these states include 249 counties, which formed the population of the study. Key data 
elements for this study included patient demographics, principal diagnosis, and whether 
the diagnosis was present on admission into the hospital (HCUP Databases, 2014). ADE 
rates were calculated among patients 65 years and older. All other age groups were be 
excluded from the analysis.  
Study Variables 
Independent Variable – Percentage of Physicians Actively E-prescribing 
 The independent variable for both Aims 1 and 2, percentage of physicians that 
actively use e-prescribing, was obtained from the ONC Health IT Dashboard – Health IT 
Adoption and Use dataset and AHRF.  
Dependent Variable – Rate of ADE hospitalizations 
 The dependent variable for the county-level analysis for Aim 1 was the rate of 
ADE hospitalizations for patients 65 years and older in the county in 2011. ADEs were 
identified using Lucado, Paez, & Elixhauser's (2011) list of specific International 
Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) diagnosis 
codes and external cause of injury codes. The list of ICD-9 codes is reprinted in Table 
3.1.  
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Table 3.1 International Classification of Diseases, Ninth Revision, Adverse Drug 
Event Code Classification 
General causes of drug-related 
adverse outcomes 
ICD-9 Diagnosis Codes 
Hormones and synthetic substitutes 962.0, 962.1, 962.2, 962.3, 962.4, 962.5, 962.6, 
962.7, 962.8, 962.9, E858.0, E932.0, E932.1, 
E932.2, E932.3, E932.4, E932.5, E932.6, E932.7, 
E932.8, E932.9 
Analgesics, antipyretics, and 
antirheumatics 
965.02, 965.09, 965.1, 965.4, 965.5, 965.61, 
965.69, 965.7, 965.8, 965.9, E850.1, E850.2, 
E850.3, E850.4, E850.5, E850.6, E850.7, E850.8, 
E850.9, E935.1, E935.1, E935.2, E935.3, E935.4, 
E935.5, E935.6, E935.7, E935.8, E935.9 
Agents that affect blood 
constituents 
964.0, 964.1, 964.2, 964.3, 964.4, 964.5, 964.6, 
964.7, 964.8, 964.9, E858.2, E934.0, E934.1, 
E934.2, E934.3, E934.4, E934.5, E934.6 E934.7 
E934.8, E934.9 
Systemic agents 963.0, 963.1, 963.2, 963.3, 963.4, 963.5, 963.8, 
963.9, E858.1, E933.0, E933.1, E933.2, E933.3, 
E933.4, E933.5, E933.8, E933.9 
Cardiovascular drugs 972.0, 972.1, 972.2, 972.3, 972.4, 972.5, 972.6, 
972.7, 972.8, 972.9, E858.3, E942.0, E942.1, 
E942.2, E942.3, E942.4, E942.5, E942.6, E942.7, 
E942.8, E942.9 
Other and unspecified drugs and 
medicinal substances 
977.0, 977.1, 977.2, 977.3, 977.4, 977.8, 977.9, 
E858.8, E858.9, E947.0, E947.1, E947.2, E947.3, 
E947.4, E947.8, E947.9 
Antibiotics 960.0, 960.1, 960.2, 960.3, 960.4, 960.5, 960.6, 
960.7, 960.8, 960.9, E856, E930.0, E930.1, 
E930.2, E930.3, E930.4, E930.5, E930.6, E930.7, 
E930.8, E930.9 
Psychotropic agents (other than 
hallucinogens, amphetamines, and 
caffeine) 
969.0, 969.1, 969.2, 969.3, 969.4, 969.5, 969.8, 
969.9, E853.0, E853.1, E853.2, E853.8, E853.9, 
E854.0, E854.8, E939.0, E939.1, E939.2, E939.3, 
E939.4, E939.5, E939.8, E939.9 
Water, mineral, and uric acid 
metabolism drugs 
974.0, 974.1, 974.2, 974.3, 974.4, 974.5, 974.6, 
974.7, E858.5, E944.0, E944.1, E944.2, E944.3, 
E944.4, E944.5, E944.6, E944.7 
Sedatives and hypnotics 967.0, 967.1, 967.2, 967.3, 967.4, 967.5, 967.6, 
967.8, 967.9, E851, E852.0, E852.2, E852.8, 
E852.9, E937.0, E937.1, E937.3, E937.4, E937.5, 
E937.6, E937.8, E937.9 
Anticonvulsants and anti-Parkinson 
drugs 
966.0, 966.1, 966.2, 966.3, 966.4, E855.0, E936.0, 
E936.1, E936.2, E936.3, E936.4 
Other anti-infectives 961.0, 961.1, 961.2, 961.3, 961.4, 961.5, 961.6, 
961.7, 961.8, 961.9, E857, E931.0, E931.1, 
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E931.2, E931.3, E931.4, E931.5, E931.6, E931.7, 
E931.8, E931.9 
Drugs effecting autonomic nervous 
system 
971.0, 971.1, 971.2, 971.3, 971.9, E855.3, E855.4, 
E855.5, E855.6, E855.8, E855.9, E941.0, E941.1, 
E941.2, E941.3, E941.9 
Central nervous system depressants 
and anesthetics 
968.0, 968.1, 968.2, 968.3, 968.4, 968.5, 968.6, 
968.7, 968.8, 968.9, E855.1, E855.2, E938.0, 
E938.1, E938.2, E938.3, E938.4, E938.5, E938.6, 
E938.7, E938.9 
Agents acting on smooth and 
skeletal muscles and respiratory 
system (e.g. muscle relaxants) 
975.0, 975.1, 975.2, 975.3, 975.4, 975.5, 975.6, 
975.7, E945.0, E945.1, E945.2, E945.3, E945.4, 
E945.5, E945.6, E945.7 
Central nervous system stimulants 
(e.g., opiate antagonists) 
970.0, 970.1, 970.8, 970.9, E854.3, E940.0, 
E940.1, E940.8, E940.9 
Agents effecting the gastrointestinal 
system (e.g., cathartics) 
973.0, 973.1, 973.2, 973.3, 973.4, 973.5, 973.6, 
973.8, E858.4, E943.0, E943.1, E943.2, E943.3, 
E943.4, E943.5, E943.6, E943.8, E943.9 
Agents effect skin, mucous 
membranes, eye, ENT, and dental 
976.0, 976.1, 976.2, 976.3, 976.4, 976.5, 976.6, 
976.7, 976.8, 976.9, E858.7, E946.0, E946.1, 
E946.2, E946.3, E946.4, E946.5, E946.6, E946.7, 
E946.8, E946.9 
Vaccines and biological substances 978.0, 978.1, 978.2, 978.3, 978.4, 978.5, 978.6, 
978.8, 978.9, 979.0, 979.1, 979.2, 979.3, 979.4, 
979.5, 979.6, 979.7, 979.9, E948.0, E948.1, 
E948.2, E948.3, E948.4, E948.5, E948.6, E948.8 
E948.9, E949.0, E949.1, E949.2, E949.3, E949.4, 
E949.5 E949.6, E949.7, E949.9 
Note. Abbreviated reprint from “Medication-Related Adverse Outcomes in U.S. Hospitals 
and Emergency Departments, 2008,” by J. Lucado, K. Paez, and A. Elixhauser, 2011, 
HCUP Statistical Brief #109, p. 11-13. Copyright 2011 by Agency for Healthcare 
Research and Quality. Reprinted with permission. 
Though ICD-9 codes are generated for billing and reimbursement purposes, 
several studies have noted the utility and current application of administrative data in 
detecting adverse events (Bates et al., 2003; Cano & Rozenfeld, 2009; Hougland, Xu, 
Pickard, Masheter, & Williams, 2006; Weingart et al., 2000). However, it should be 
noted that the underreporting of ADEs in an administrative dataset may result in an 
underestimate of ADE hospitalizations in this study (Cano & Rozenfeld, 2009; Hohl et 
al., 2013).  
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Encinosa & Bae (2013) identified hospital-acquired ADEs by redesigning 
Lucado, Paez, & Elixhauser's (2011) algorithm to flag ADEs that were coded as not 
being POA. For this study, the Lucado and colleagues algorithm was modified to flag 
ADEs that were also coded as being POA. In other words, a hospital discharge was 
identified as an ADE hospitalization if it was: (1) present on admission; and (2) had an 
ICD-9 code that was considered an ADE. Both criteria were utilized in this definition to 
ensure that ADEs were acquired prior to hospitalization. Following the protocol utilized 
by Lucado et al. (2011), discharges with ICD-9 codes (965.00, 965.01, 969.6, 969.7, 
E850.0, E854.1, E854.2, E935.0, E939.6, E939.7, E950.0-950.9, E962.0-E962.9, E980.0-
E980.9) that pertain to accidental poisonings, self-inflicted poisonings, and/or assault 
were excluded. Additionally, hospitals that reported all diagnoses as being POA, 
hospitals with over 20% of discharges with missing POA indicators for non-missing 
diagnoses, and discharges with missing POA information for non-missing diagnoses were 
excluded from the analysis. 
Considering that only serious ADEs result in hospitalizations, ADE 
hospitalizations among older adults will reflect the “safety and appropriateness of 
ambulatory prescribing” (Thürmann, 2003). To calculate county-level rates, the 
frequency of ADEs that result in hospitalization was divided by the population at risk of 
an ADE or those that were taking any prescription medications. Data from the National 
Health and Nutrition Examination Survey (NHANES) indicated that 89.7% of individuals 
65 years and over have taken at least one prescription drug in the past 30 days (National 
Center for Health Statistics, 2013). Given that approximately 90% of older adults took at 
least one prescription medication, this analysis assumed that all older adults were at risk 
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of an ADE. Thus, the ADE hospitalization rate calculation was the frequency of ADEs 
that result in hospitalization divided by the population of 65 years and older in the 
county. Additionally, to supplement the county ADE hospitalization rate analysis, a 
discharge-level analysis was conducted. The discharge-level analysis determined what 
factors were associated with having a higher odds of having an ADE hospitalization. The 
second portion of Aim 1 analysis utilized an outcome variable of whether or not an ADE 
hospitalization occurred.  
The dependent variable for Aim 2 was the change in rates of ADE 
hospitalizations between the years 2008 and 2011 that occur among the older adults in a 
county. The identification of ADE hospitalization was identical to that used in the first 
portion of Aim 1. The ADE hospitalization rate was calculated for the year 2008 and 
2011 for each county.   
Control Variables 
 County-level control variables were obtained from the ARHF, a database on 
healthcare facilities maintained by the HRSA. These control variables were included: 
total number of hospitals, total hospital beds, percent of residents with less than high 
school education, percent of residents living in poverty, and percent of African American 
residents.  
Study Design 
 The county-level analysis of Aim 1 utilized a cross-sectional study design for the 
year 2011 to determine the association between the rate of e-prescribing and ADE 
hospitalizations among older adults at the county-level. The discharge-level analysis of 
Aim 1 also utilized a cross-sectional study design to determine what factors were 
51 
associated with increased odds of having an ADE hospitalization. State and county FIPS 
codes were used to merge HCUP SID, ONC data, and the AHRF. Aim 2 utilized a pre- 
and post- intervention study design to examine the association between the 2008-2011 
change in e-prescribing rates and the county-level rates of ADE hospitalizations.  
Analytic Approach 
Aim 1. Bivariate analysis assessed the correlation of the percentage of e-
prescribing providers with the rate of ADE hospitalizations at the county level. A 
multivariate analysis, using linear regression, determined significant differences in the 
rate of county-level hospitalizations for ADEs for patients 65 years and older, while 
controlling for county-level characteristics. Additionally, for the analysis utilizing 
discharge-level data, Wald chi-square tests determined the association of e-prescribing 
adoption rates with the rate of ADE hospitalizations. Logistic regression determined the 
adjusted odds of having an ADE hospitalization among older adults, while controlling for 
patient- and county- level characteristics.   
Aim 2. Student’s t-test assessed the difference of the 2008 and 2011 rate of ADE 
hospitalizations and physician e-prescribing rates. Multivariate analysis using Poisson 
regression modeled (as shown below) the number of ADE hospitalizations among 
patients 65 years and older (num_ADE11). The total population of older adults 
(den_ADE11) offset this model. Covariates for the model included the rate of ADE 
hospitalizations for 2008 (rate_ADE08), the change in e-prescribing rate from 2008-2011 
(diffrate_eRx), and county-level characteristics for 2011 (γ in equation below).  
Overdispersion was detected and required negative binomial regression models for 
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............At the county level, we sought to determine whether the proportion of physicians 
using electronic prescribing (e-prescribing) was associated with the hospitalization rate 
for adverse drug events (ADEs) among patients aged 65 and older.  
Methods.  
We conducted an ecological and discharge-level analysis of the relationship 
between county e-prescribing rates and ADE hospitalizations. Data from the 2011 State 
Inpatient Databases, the Office of the National Coordinator Health IT Dashboard, and the 
Area Health Resource File were gathered for six states: Arizona, Florida, Maryland, 
Michigan, New Jersey, and Washington. The analysis was restricted to adults 65 years 
and older. The independent variable, the rate of e-prescribing, was an ecological measure 
for both analyses. Our first analysis examined county rates of ADE hospitalization, while 
the second analysis examined the odds that a discharge would have been ADE associated, 
versus other causes. Multivariable linear and logistic regressions were utilized for county- 
and discharge- level analysis, respectively.  
Results.  
Results indicated that county e-prescribing rates were not significantly associated 
with county ADE hospitalization rates among older adults (p=0.4705). Further, after 
adjusting for patient, provider, health infrastructure, and community factors, the county e-
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prescribing rate was not a significant factor in determining the odds of an ADE 
hospitalization.  
Conclusion.  
Though the adoption of e-prescribing has continued to increase throughout the 
U.S., our findings indicate that population-level benefits, such as decreased ADE 
hospitalization among older adults, have yet to be seen. Researchers and policy makers 
must continue to monitor the population impact that the implementation of HITs is 
having on the health of the nation.  
Introduction 
Patient safety and quality of care have received increased attention from the 
healthcare industry since the release of the 1999 Institute of Medicine report, To Err is 
Human. This heightened attention has continued to grow as tools to identify adverse drug 
events and reactions are becoming widely available. Adverse drug events (ADEs), 
defined as injuries that are the result of medication, are of particular public health 
importance because of the increasingly high number of Americans taking prescription 
drugs, particularly older Americans. Across 2007-2010, approximately 40% of 
Americans aged 65 years and over used five or more prescription drugs in the past 30 
days (U.S. Food and Drug Administration, 2013). Occurrences of ADEs are also seen in 
older adults nearly 7 times more often than among adults younger than 65 years, making 
them an important indicator of patient safety (Lucado, Paez, & Elixhauser, 2011).  
ADEs that occur prior to hospital admissions are of particular interest because 
they are three times more common than ADEs that originate during a hospital stay 




between 2.4% and 9.0% are caused by ADEs that are present at hospital admission (D. 
Bates, Cullen, & Laird, 1995; Budnitz et al., 2005; Leape et al., 1999; von Laue, 
Schwappach, & Koeck, 2003). von Laue et al. (2003) determined that over half of ADEs 
were preventable. With the high risk and cost of ADEs in the older patient population, it 
is essential to ensure that effective and appropriate ambulatory prescribing habits are 
followed and ADEs that result in hospitalization are prevented (Thürmann, 2003; 
Willlams, 2002). 
 Kaushal, Barker, & Bates (2001) describe the potential of health information 
technology (HIT) to improve patient safety in the outpatient setting. Additionally, Bates 
& Gawande (2003) argue that electronic prescribing (e-prescribing) provides a method to 
reduce errors by preventing errors and adverse events. E-prescribing provides a tool to 
overcome the common risk factors of ADEs, such as lack of communication among 
concurrent prescribers (Boockvar et al., 2009; Green, Hawley, & Rask, 2007; Jena, 
Goldman, Weaver, & Karaca-Mandic, 2014). 
In an effort to increase the adoption of e-prescribing, federal legislation and 
incentive programs have been established. These programs include the Medicare 
Prescription Drug, Improvement, and Modernization Act of 2003, the e-prescribing 
incentive program as part of the Medicare Improvements for Patients and Providers Act 
of 2008, and most recently the electronic health record incentive program through the 
Health Information Technology for Economic and Clinical Health Act of the American 
Recovery and Reinvestment Act of 2009. The combination of incentives has resulted in 




in April 2014 (Gabriel & Swain, 2014). However, whether the increase in HITs has 
resulted in meaningful population health improvements is undetermined.  
Previous studies examining the impact of HIT on ADEs have been limited to a 
hospital setting and determining the rate of ADEs occurring within a hospital stay (D W 
Bates et al., 1999; Colpaert et al., 2006; Devine et al., 2010; Evans et al., 1994, 1998; 
Gandhi et al., 2005; Gurwitz et al., 2008; King, Paice, Rangrej, Forestell, & Swartz, 
2003; Mullett, Evans, Christenson, & Dean, 2001; Pestotnik, Classen, Evans, & Burke, 
1996; Steele et al., 2005; Upperman et al., 2005; van Doormaal et al., 2009). No studies 
were found that examined the impact of HIT use in ambulatory settings on ADE 
hospitalizations or provided a population-based approach. The population-based 
approach of this study examines the impact of the Office of the National Coordinator for 
Health Information Technology (ONC) call for interoperability among all parts of the 
health care system, rather than focusing on individual patients. This study provides a 
population-based approach to examine the association of e-prescribing on 
hospitalizations caused by ADEs, specifically among older adults. 
Methodology 
Theoretical model  
An ecological modification of Ancker, Kern, Abramson, & Kaushal's (2012) Triangle 
Model was used as a theoretical framework for this analysis (See Figure 2.2). We 
conducted separate county- and discharge-level analyses to determine the association 
between e-prescribing and ADE hospitalization rates. The four main constructs of the 




modified the framework to account for each of these constructs at an ecological level: 
technology, adopters/providers, healthcare infrastructure, and community/patients.  
Data sources   
Data were drawn from three datasets: 2011 Healthcare Cost and Utilization Project 
(HCUP) State Inpatient Databases (SID), the ONC Health IT Dashboard – Health IT 
Adoption and Use dataset, and the Health Resources and Services Administration 
(HRSA) Area Health Resource File (AHRF). Datasets were merged using state and 
county Federal Information Processing Standards (FIPS) codes. Key data elements for 
this study from HCUP SID include patient demographics, such as sex, age, race, number 
of chronic conditions, and length of stay; principal diagnosis; and whether the diagnosis 
was present on admission (POA) (HCUP Databases, 2014). The POA indicator allows for 
the identification of ADEs that occurred in the community and are likely to be associated 
with outpatient provider prescriptions, rather than during a hospital stay. This study was 
exempt by the University of South Carolina Institutional Review Board. 
Study Sample 
Due to budgetary constraints and per-state costs for HCUP SID files, the analysis 
was limited to data from 249 counties within 6 states: Arizona, Florida, Maryland, 
Michigan, New Jersey, and Washington. States were chosen due to the availability of 
patient residence and POA indicator data elements, while also allowing for the 
representation of at least one state from each of the four major Census regions.  
To ensure that our analysis did not inaccurately estimate the association between 
e-prescribing and ADE hospitalizations, several criteria were used to exclude discharges, 




missing electronic prescribing rates were excluded from both analyses (n=6). Hospitals 
and discharges with missing or partial information were also excluded. Specifically, 
hospitals that report all diagnoses as POA, and hospital with over 20% of discharges with 
missing POA indicators for non-missing diagnoses were excluded. The number of 
hospitals represented was reduced from 869 to 745 after hospital exclusion criteria were 
applied.  We also excluded discharges with missing age or age less than 65 years, missing 
POA information for non-missing diagnoses, and missing county of residence. Lastly, 
discharges for out-of-state patients were excluded from these analyses. The final study 
population for the discharge level analysis consisted of 2,484,768 discharges across 243 
counties. 
In addition to the above criteria, the county-level analysis used one additional 
exclusion criterion. To avoid artificially low ADE hospitalization rates, if a hospital was 
excluded due to the criteria listed above, the county of the hospital was excluded from the 
sample.  Twelve hospitals were included despite not having county data available in the 
SID. We deduced the location of these hospitals based on the county of patient residence 
with the highest percentage of discharges. We chose not to exclude the counties of these 
12 hospitals because while most of the hospital’s patients came from a single county, 
those discharges represented less than 5% of county discharges (See Appendix A for 
details). County data were also not available for the state of Michigan. The final sample 
for the county-level analysis consisted of 111 counties.  
Dependent variable 
Following the algorithm utilized by Encinosa & Bae (2013), we modified the 




the community and outside of a hospitalization, our modification defines ADE 
hospitalizations as hospital discharges that had [1] a POA indicator and [2] an 
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) 
diagnosis code for an ADE. Both criteria were used to ensure that ADEs were acquired 
prior to hospitalization. Lucado, Paez, & Elixhauser's (2011) list of ICD-9 codes and 
external cause of injury codes were used to determine ICD-9 codes for ADEs. Discharges 
with ICD-9 codes that pertain to accidental poisonings, self-inflicted poisonings, and/or 
assault were not flagged as ADEs. For the county-level analysis, the ADE hospitalization 
rate was calculated by dividing the number of ADE hospitalizations in the patient county 
of residence in 2011 by the older adult population in the county in 2011. The discharge-
level analysis utilized a dichotomous indicator of having an ADE hospitalization.  
Independent variable 
The ONC Health IT Dashboard – Health IT Adoption and Use dataset was 
utilized to determine the independent variable, the percentage of physicians e-prescribing 
in each county. The ONC Health IT Dashboard is an open government project that 
provides percentage of e-prescribers on the country’s largest e-prescribing network, 
Surescripts, by county (Office of the National Coordinator for Health Information 
Technology, 2014). Surescripts is utilized by nearly 95% of U.S. community pharmacies 
(“Surescripts,” 2014b). Two out of three healthcare professionals utilized one of the top 
ten electronic medical records, which includes medication history functionalities with the 
ability for risk management of ADEs, drug-drug interactions, and drug-allergy 
interactions via Surescripts (Surescripts, 2014a). Of the non-dominant EMR vendors, 




adoption rate of counties was categorized as either high/low when compared to the 
median rate or into quartiles.  
Control variables 
Multivariable analyses control for potential confounders at two levels.  At the 
county level, the HRSA AHRF was the source for control variables. Adopters/providers 
were determined through the AHRF by including the number of primary care physicians 
per 1,000 population in the county (expressed in quartiles). Healthcare infrastructure was 
represented by including the number of hospital beds per 1,000 population in the county 
(expressed in quartiles), and whether the county had a hospital. Last, the community 
variables utilized included whether a county was rural (defined by the 2003 Urban 
Influence Code of greater than 3), the percentage greater than 65 years old, the 
percentage of population living in poverty (continuous in county-level analysis; 
expressed in quartiles for discharge-level analysis), the percent African American 
population, and the percentage of the population with less than a high school education 
(continuous in county-level analysis; divided into quartiles for discharge-level analysis).  
At the discharge level, patient demographic information and whether a county was 
designated a Health Professional Shortage Area (Whole, Partial, None) was also included 
in the analysis. This included the patient sex, age group (65-74, 75-84, 85+), 
race/ethnicity (White, African American, Hispanic, Other), number of chronic conditions 
(0-20), and length of hospital stay in days.  
Analytic Approach  
A cross-sectional ecological study design was implemented to determine the 




assigned to counties based on the patient county of residence. Unadjusted ADE rates 
were estimated across county characteristics of interest. A multivariate analysis, using 
linear regression, was used to identify county characteristics that influence county ADE 
rates.  
Second, a discharge-level analysis was used to determine whether the odds of 
having an ADE hospitalization were associated with county e-prescribing rates. 
Differences across county e-prescribing adoption rates were assessed using Wald chi-
square tests (α = 0.05). Multivariate logistic regression was utilized to identify patient and 
county characteristics that were associated with having an ADE hospitalization. Five 
logistic regression models were conducted to determine the impact of each major 
construct of the theoretical framework: Technology, Patient, Adopters/Providers, 
Healthcare Infrastructure, and Community.  
Results – County Analysis 
Table 4.1 describes the counties in our dataset, by the e-prescribing rate of the 
county. Low adoption counties had a proportionately larger African American population 
and population with less than a high school education when compared to high e-
prescribing counties (p=0.0267 and p=0.0302, respectively). High e-prescribing counties 
had a greater proportion of the population aged 65 years and older (p=0.0106) 
Table 4.1 Descriptive Summary of County Characteristics by Electronic Prescribing  
(E-Prescribing) Rates, 2011 
Characteristics of Interest 
















Adopters / Providers  
Primary care physicians (per 
1,000) 




0.00 – 0.36 25.2 23.0 28.0 0.5422 
0.37 – 0.53 24.3 21.3 28.0 0.4138 
0.54 – 0.70 27.0 29.5 24.0 0.5156 
0.71 – 1.86 23.4 26.2 20.0 0.4407 
  
Healthcare Infrastructure  
Hospital beds (per 1,000)     
0.00 – 1.13 24.3 24.6 24.0 0.9425 
1.14 – 1.98 25.2 21.3 30.0 0.2943 
1.99 – 2.98 26.1 24.6 28.0 0.6841 
2.99 – 21.4 24.3 29.5 18.0 0.1597 
No hospital in county 12.6 13.1 12.0 0.8603 
  
Community  
Rural 40.5 32.8 50.0 0.0661 
Population ≥ 65 years (%) 17.2 18.8 15.2 0.0106 
Population living in poverty (%) 16.4 15.6 17.3 0.2978 
African American population (%) 12.2 9.9 15.0 0.0267 
Population with < high school 
education (%) 
10.5 9.7 11.5 0.0302 
 
The median unadjusted ADE rate per 1,000 older adults was 0.67 for the counties 
studied. No factors significantly related to unadjusted ADE hospitalization rates were 
detected (See Table 4.2). 
Table 4.2 Unadjusted Adverse Drug Event Rate (per 1,000 older adults) by County 
Characteristics, 2011 (n=111 counties) 












Technology    
e-Prescribing Rate    
0 – 27% 0.71 0.08 1.0000 
28 – 34% 0.74 0.06 0.9178 
35 – 45% 0.64 0.05 1.0000 
≥ 46% (referent) 0.60 0.06  
 
Adopters / Providers    




0.00 – 0.36 0.68 0.08 1.0000 
0.37 – 0.53 0.64 0.06 1.0000 




0.71 – 1.86 (referent) 0.70 0.07  
 
Healthcare Infrastructure    
Hospital beds (per 1,000)    
0.00 – 1.13 0.67 0.07 1.0000 
1.14 – 1.98 0.63 0.05 1.0000 
1.99 – 2.98 0.62 0.06 1.0000 
2.99 – 21.4 (referent) 0.75 0.07  
Hospital availability   0.1461 
Hospital in county (referent) 0.55 0.11  
No hospital in county 0.68 0.03  
 
Community    
Location   0.0972 
Rural 0.60 0.05  
Urban (referent) 0.71 0.04  
 
In adjusted analysis (See Table 4.3), the e-prescribing rate was not significantly 
associated with the county ADE rate among older adults. Counties without a hospital had 
a significantly lower ADE rate than counties with a hospital (p=0.0305). In addition, 
counties with higher African American populations had slightly higher ADE rates 
(p=0.0377).  
Table 4.3 Factors influencing Adverse Drug Event Rate (per 1,000) among older 
adults, 2011 (n=111 counties) 







Technology    
e-Prescribing Rate -0.0015 0.0020 0.4705 
 
Adopters / Providers    
Primary care physicians (per 1,000)    
0.00 – 1.13 0.0819 0.1318 0.5356 
1.14 – 1.98 0.0153 0.1027 0.8815 
1.99 – 2.98 0.0343 0.0910 0.7073 
0.71 – 1.86 (referent) Ref. Ref. Ref. 
 
Healthcare Infrastructure    
Hospital beds (per 1,000)    
0.00 – 1.13 0.1178 0.1278 0.3589 
1.14 – 1.98 -0.0604 0.1001 0.5475 




2.99 – 21.4 (referent) Ref. Ref. Ref. 
No hospital in county (versus hospital 
in county) 
-0.2739 0.1247 0.0305 
 
Community    
Rural (versus Urban) -0.1030 0.0818 0.2114 
Population ≥ 65 years (%) -0.0040 0.0056 0.4861 
Population living in poverty (%) 0.0067 0.0078 0.3997 
African American population (%) 0.0063 0.0030 0.0377 
Population with < high school 
education (%) 
-0.0071 0.0133 0.5982 
 
Results – Discharge-level Analysis 
Table 4.4 displays the characteristics of hospital discharges in the study 
population, subset by the county e-prescribing rate. Discharges for patients who resided 
in the highest e-prescribing counties were more likely male, between the ages of 65-74, 
white, and had a shorter length of hospital stay. The counties in which these patients 
reside have fewer primary care physicians, fewer hospital beds per population, are more 
likely to be whole county HPSA, are more likely to be rural, and have close to median 
levels of poverty and high school education levels.  
Table 4.4 Characteristics of Hospital Discharges among Older Adults, by Electronic 
Prescribing (E-Prescribing) Rates, 2011 
Characteristics of Interest 










     
All Discharges  100.0 52.5 47.5  
Number of Discharges 2,484,768 1,304,420 1,180,348  
     
Patient      
Male
a
 44.2 45.1 43.3 <0.0001 
Age Group     
65 – 74 38.3 39.2 37.3 <0.0001 
75 – 84 37.5 37.6 37.5 0.0518 
85+ 24.2 23.2 25.3 <0.0001 
Race
b 
    
White 74.9 82.3 66.7 <0.0001 




Hispanic 7.7 4.2 11.7 <0.0001 
Other 2.7 2.4 3.0 <0.0001 
Number of chronic conditions, 
mean 
6.7 6.7 6.7 <0.0001 
Length of stay, mean 5.3 5.1 5.5 <0.0001 
     
Adopters / Providers     
Primary care physicians (per 
1,000) 
    
0.00 – 0.57 25.5 24.6 26.5 <0.0001 
0.58 – 0.71 25.3 34.1 15.6 <0.0001 
0.72 – 0.84 24.1 18.0 30.9 <0.0001 
0.85 – 1.85 25.1 23.3 27.0 <0.0001 
     
Healthcare Infrastructure     
Hospital beds (per 1,000)     
0.00 – 2.21 24.6 24.8 24.4 <0.0001 
2.22 – 2.89 25.3 36.1 13.4 <0.0001 
2.90 – 3.43 26.7 21.4 32.5 <0.0001 
3.44 – 21.4 23.4 17.6 29.7 <0.0001 
No hospital in county 0.7 0.9 0.5 <0.0001 
Health Professional Shortage 
Area (HPSA) 
    
Whole 29.7 31.6 27.6 <0.0001 
Partial 65.1 65.2 65.1 0.1368 
None 5.2 3.3 7.3 <0.0001 
     
Community     
Rural 9.3 10.1 8.4 <0.0001 
Population living in poverty     
0.0 – 11.8 24.9 20.8 29.5 <0.0001 
11.9 – 15.4 25.7 30.4 20.6 <0.0001 
15.5 – 17.8 24.4 26.2 22.4 <0.0001 
17.9 – 36.0 25.0 22.7 27.6 <0.0001 
Population with < high school 
education 
    
0.0 – 7.1 25.7 24.9 26.6 <0.0001 
7.2 – 8.7 24.2 24.9 23.4 <0.0001 
8.8 – 10.2 25.0 33.6 15.4 <0.0001 
10.3 – 24.7 25.2 16.6 34.7 <0.0001 
State     
AZ 9.9 17.5 1.6 <0.0001 
FL 39.7 41.3 37.9 <0.0001 
MD 8.9 8.5 9.5 <0.0001 
MI 18.7 13.9 24.1 <0.0001 
NJ 15.2 8.2 22.9 <0.0001 





All differences were assessed using Wald chi-square tests 
a 
17 discharges were missing sex 
b
 108,693 discharges were missing race 
 
A total of 5,956 of 2,484,768 (0.24%) discharges were due to ADEs that occurred 
in the community. The unadjusted proportion of all hospitalizations among persons 65 
and older that included a community ADE was higher for counties with high e-
prescribing adoption rates (0.25 versus 0.22; see Table 4.5). Other factors that were 
associated with proportionately more ADE hospitalizations included being between the 
aged of 65-74 years, living in a county with more hospital beds per population, living 
outside of a HPSA, and residing in Washington, Arizona, or Florida.  
Table 4.5 Percent of Older Adult Discharges that Included a Community ADE, by 
Electronic Prescribing (E-Prescribing) Rates, 2011 
Characteristics of Interest 










     
All Discharges (n=2,484,768) 0.24 0.25 0.22 <0.0001 
     
Patient     
Sex
a 
   0.8829 
Male 0.21 0.22 0.20  
Female 0.26 0.28 0.24  
Age Group
b 
    
65 – 74 0.32 0.34 0.30 0.0180 
75 – 84 0.21 0.22 0.20 0.0740 
85+ 0.16 0.17 0.14 0.3472 
Race     
White 0.25 0.26 0.23 <0.0001 
African American 0.23 0.25 0.22 <0.0001 
Hispanic 0.19 0.24 0.17 <0.0001 
Other 0.23 0.22 0.25 0.0042 
     
Adopters / Providers     
Primary care physicians 
(per 1,000) 
    
0.00 – 0.57 0.22 0.24 0.21 0.0935 
0.58 – 0.71 0.25 0.26 0.25 <0.0001 




0.85 – 1.85 0.23 0.25 0.21 0.0260 
     
Healthcare Infrastructure     
Hospital beds (per 1,000)     
0.00 – 2.21 0.23 0.25 0.21 0.3581 
2.22 – 2.89 0.24 0.24 0.23 <0.0001 
2.90 – 3.43 0.24 0.27 0.22 <0.0001 
3.44 – 21.4 0.25 0.27 0.23 <0.0001 
Number of hospitals in 
county 
   n/a 
0 0.23 0.25 n/a  
1 or more 0.24 0.25 0.22  
Health Professional 
Shortage Area (HPSA) 
    
Whole 0.26 0.27 0.26 0.4004 
Partial 0.23 0.25 0.21 0.1806 
None 0.21 0.27 0.19 <0.0001 
     
Community     
Rurality    0.6148 
Urban 0.24 0.26 0.22  
Rural 0.22 0.22 0.22  
Population living in poverty     
0.0 – 11.8 0.21 0.22 0.21 <0.0001 
11.9 – 15.4 0.25 0.26 0.25 <0.0001 
15.5 – 17.8 0.26 0.28 0.22 <0.0001 
17.9 – 36.0 0.24 0.25 0.22 <0.0001 
Population with < high 
school education 
    
0.0 – 7.1 0.24 0.26 0.22 0.4082 
7.2 – 8.7 0.25 0.26 0.23 0.2071 
8.8 – 10.2 0.26 0.27 0.25 <0.0001 
10.3 – 24.7 0.21 0.22 0.21 <0.0001 
State     
AZ 0.28 0.28 0.28 <0.0001 
FL 0.25 0.26 0.24 0.7379 
MD 0.24 0.22 0.26 <0.0001 
MI 0.22 0.24 0.21 <0.0001 
NJ 0.18 0.19 0.17 <0.0001 
WA 0.29 0.29 0.29 <0.0001 
Notes:  
All differences were assessed using Wald chi-square tests, α = 0.05 
n/a – sample size < 5 
a
 17 discharges were missing sex 
b





The multivariate logistic model (see Table 4.6) estimated the odds of having an 
ADE hospitalization versus other diagnoses. Because our approach is based on all 
hospitalizations rather than all persons, our model controls for potential differences in the 
likelihood of hospitalization associated with regional variation in practice patterns. The 
first model included only the county e-prescribing rate. It found that residents of a county 
with a 27 -35% adoption rate were less likely to have an ADE hospitalization when 
compared to residents living in counties with an adoption rate of over 48%. When patient 
demographic information was added into the model (model 2), the odds of residents of a 
county with 27-35% adoption rate no longer were significant. Other factors that were 
associated with having higher odds of an ADE hospitalization, when taking patient 
demographics into account, included being female and having additional chronic 
conditions. When adding the number of primary care physicians per 1,000 population 
into the model (model 3), being female, having additional chronic conditions, and living 
in a county that have 0.72 – 0.84 primary care physicians per 1,000 population were 
significantly associated with increased odds of ADE hospitalizations. Model 4 took 
healthcare infrastructure into account there were no changes in significant factors. The 
final model (model 5) included all the previous variables and community factors. Model 
5 indicates that the county e-prescribing rates are not significantly associated with the 
odds of an older adult having an ADE hospitalization. Additionally, the model indicates 
that the odds of an ADE hospitalization are higher for females, having more chronic 
conditions, living in counties with 8.8 – 10.2% of the population having less than a high 







Table 4.6 Adjusted Odds of Having an Adverse Drug Event Hospitalization among Older Adults, 2011 
Characteristics of Interest 
Model 1 
OR (95% CI) 
Model 2 
OR (95% CI) 
Model 3 
OR (95% CI) 
Model 4 
OR (95% CI) 
Model 5 
OR (95% CI) 
      
Technology      
Electronic Prescribing Rate      
0 – 26% 0.93 (0.86 – 1.00) 0.95 (0.88 – 1.02) 0.94 (0.88 – 1.02) 0.94 (0.87 – 1.01) 1.08 (1.00 – 1.17) 
27 – 35% 0.85 (0.79 – 0.92) 0.93 (0.86 – 1.01) 0.89 (0.82 – 0.96) 0.89 (0.82 – 0.97) 0.94 (0.86 – 1.03) 
36 – 47% 1.04 (0.97 – 1.11) 1.03 (0.96 – 1.10) 0.99 (0.93 – 1.07) 1.02 (0.95 – 1.11) 1.07 (0.98 – 1.17) 
≥ 48% Ref. Ref. Ref. Ref. Ref. 
      
Patient      
Sex      
Male  Ref. Ref. Ref. Ref. 
Female  1.33 (1.26 – 1.41) 1.34 (1.27 – 1.41) 1.33 (1.26 – 1.41) 1.33 (1.26 – 1.41) 
Age Group      
65 – 74  Ref. Ref. Ref. Ref. 
75 – 84  0.65 (0.61 – 0.69) 0.65 (0.61 – 0.68) 0.65 (0.61 – 0.69) 0.65 (0.61 – 0.69) 
85+  0.46 (0.43 – 0.50) 0.46 (0.43 – 0.50) 0.46 (0.43 – 0.50) 0.46 (0.43 – 0.50) 
Race      
White  Ref. Ref. Ref. Ref. 
African American  0.89 (0.81 – 0.97) 0.87 (0.80 – 0.95) 0.86 (0.79 – 0.94) 0.87 (0.80 – 0.96) 
Hispanic  0.78 (0.70 – 0.87) 0.73 (0.65 – 0.82) 0.74 (0.66 – 0.82) 0.75 (0.67 – 0.85) 
Other  0.93 (0.79 – 1.09) 0.93 (0.79 – 1.09) 0.93 (0.79 – 1.09) 0.93 (0.79 – 1.09) 
Each additional chronic condition  1.04 (1.03 – 1.05) 1.04 (1.03 – 1.05) 1.04 (1.03 – 1.05) 1.04 (1.03 – 1.05) 
Each additional day in length of stay  0.93 (0.92 – 0.93) 0.93 (0.79 – 1.09) 0.93 (0.92 – 0.93) 0.93 (0.92 – 0.93) 
      
Adopters / Providers      
Primary care physicians (per 1,000)      
0.00 – 0.57   0.93 (0.86 – 1.01) 0.97 (0.88 – 1.06) 0.94 (0.85 – 1.05) 
0.58 – 0.71   1.05 (0.97 – 1.13) 1.04 (0.95 – 1.13) 0.92 (0.83 – 1.01) 
0.72 – 0.84   1.20 (1.11 – 1.29) 1.20 (1.10 – 1.31) 0.96 (0.86 – 1.07) 
0.85 – 1.85   Ref. Ref. Ref. 
      
Healthcare Infrastructure      






0.00 – 2.21    0.92 (0.84 – 1.01) 0.91 (0.82 – 1.01) 
2.22 – 2.89    0.92 (0.84 – 1.00) 0.89 (0.81 – 0.98) 
2.90 – 3.43    0.95 (0.87 – 1.04) 0.97 (0.89 – 1.06) 
3.44 – 21.4    Ref. Ref. 
Number of hospitals      
0    0.96 (0.70 – 1.31) 1.08 (0.79 – 1.48) 
1 or more    Ref. Ref. 
Health Professional Shortage Area 
(HPSA) 
     
Whole    1.12 (0.98 – 1.29) 0.95 (0.81 – 1.12) 
Partial    1.03 (0.90 – 1.18) 0.87 (0.75 – 0.93) 
None    Ref. Ref. 
      
Community      
Rurality      
Urban     Ref. 
Rural     0.84 (0.75 – 0.93) 
Population living in poverty      
0.0 – 11.8     Ref. 
11.9 – 15.4     1.05 (0.94 – 1.17) 
15.5 – 17.8     1.11 (0.99 – 1.26) 
17.9 – 36.0     1.08 (0.95 – 1.24) 
Population with < high school 
education 
     
0.0 – 7.1     Ref. 
7.2 – 8.7     1.07 (0.94 – 1.21) 
8.8 – 10.2     1.13 (1.02 – 1.25) 
10.3 – 24.7     1.09 (0.98 – 1.21) 
State      
AZ     Ref. 
FL     1.13 (0.96 – 1.34) 
MD     1.20 (1.06 – 1.36) 
MI     1.00 (0.87 – 1.13) 






WA     1.32 (1.12 – 1.55) 
Note: Bold indicates significantly different from the reference group (α=.05) 




Neither the county- nor the discharge- level analysis found e-prescribing rates at 
the county level to be significantly associated with community-occurring ADE 
hospitalizations. Previous research in inpatient settings, including pediatric hospitals and 
intensive care units, have found no direct effect on ADEs (Evans et al., 1995; King et 
al.,2003; Upperman et al., 2005; van Doormaal et al., 2009). Research in other settings, 
such as a primary care clinic and long-term care facility, have demonstrated improved 
adherence to best-practice guidelines, but have been unable to demonstrate a reduction in 
ADE rates (Gurwitz et al., 2008; Steele et al., 2005). 
 Rogers' (1995) Diffusion of Innovation theory explains that the rate of innovation 
adoption gains momentum after 20% and continues to increase at an accelerated rate. The 
mean e-prescribing rate for studied counties in 2011 was 36.5%. Rogers’ theory 
categorizes adopters during this stage in the “early majority”. The rate of adoption was in 
the process of accelerating during our study time period. The national rate of e-
prescribing increased from 7% in December 2008 to 70% in April 2014 (Gabriel & 
Swain, 2014). Thus, theoretically, our studied counties comprised of only early adopters.   
 Westphal & Shortell (2014) found that early adopters of total quality management 
practices were more likely to adapt technologies to improve efficiencies within their 
organizations, while late adopters were more likely to conform to norms by adopting well 
established programs. Studies also demonstrate that the true value of technology is how it 
is utilized by individuals and organizations (Karsh, Weinger, Abbott, & Wears, 2010; 
Prince & Herrin, 2007). These studies demonstrate the need to address organizational and 
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human factor changes to avoid unintended consequences (Damberg et al., 2009; 
Edmondson, Bohmer, & Pisano, 2001; Menachemi, Burke, & Brooks, 2004; Nanji et al., 
2011). An explanation for our lack of association may be that early adopters did not 
demonstrate early gains in patient safety indicators because they were still adapting their 
use of the technology into their organization to improve long-term efficiencies. Thus, the 
focus on long-term gains restricts our ability to view short-term improvements. Though 
we hypothesized increased e-prescribing rates would be associated with lower ADE 
hospitalization rates, we believe that the low level of adoption of e-prescribing nationally 
in 2011 may have inhibited our ability to detect any differences.  
County-level analysis findings 
In the county-level analysis, two major factors were significantly associated with 
county-level ADE hospitalization rates: the percentage of African American population 
in the county (p=0.0377) and whether the county had a hospital (p=0.0305).  
Discharge-level analysis findings 
The discharge-level analysis identified that being female and having a greater 
number of chronic conditions was associated with an increased odds of ADE 
hospitalization, while being older than 75 years, living in HPSA or rural areas, being 
African American or Hispanic, and having longer hospital stays were associated with 
reduced odds of ADE hospitalizations. 
Living in Maryland and Washington resulted in higher odds of ADE 
hospitalizations when compared to Arizona. The state variation in odds of an ADE 
hospitalization cannot be explained by variations in e-prescribing rates or POA reporting 
experience. In 2011, the states studied varied in e-prescribing rates from lowest to highest 
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in the following order: New Jersey (22%), Florida (26%), Maryland (29%), Arizona 
(33%), Michigan (37%), and Washington (37%) (Office of the National Coordinator for 
Health Information Technology, 2014). Additionally in 2011, Arizona, Michigan, New 
Jersey and Washington had been reporting POA data to HCUP for 3 years, while Florida 
and Maryland had been reporting HCUP POA data for 4 years.  
Comparing the County- and Discharge-level analyses 
While the county-level analysis found that counties without a hospital had lower 
ADE hospitalization rates than counties with a hospital, the discharge-level analysis did 
not detect a similar difference. However, the discharge-level findings did identify that 
living in rural areas results in reduced odds of having an ADE hospitalization. Over half 
(57%) of the studied counties without a hospital were located in rural areas.  Literature 
shows that rural areas tend to have lower adoption of HITs that urban areas (Bahensky, 
Jaana, & Ward, 2008). A possible explanation for this phenomenon may be that areas 
with limited healthcare providers and infrastructure may communicate and coordinate the 
prescription management of patients better than areas with higher provider saturation. 
Additional research is necessary to determine why ADE hospitalization rates were lower 
in rural counties when compared to urban counties and why areas without hospitals had 
lower odds of having an ADE hospitalization.  
While the percentage of African American populations in a county was 
significantly associated with higher county-level ADE hospitalization rates, the 
discharge-level analysis revealed that if the race of the patient was African American the 
odds of an ADE hospitalization were reduced. While the county-level analysis used the 
percentage of African American populations in the county as a proxy for patient 
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demographics, the discharge-level analysis indicated how the actual race of the patient 
impacts their odds of having an ADE hospitalization. Future studies should aim to 
determine racial differences in susceptibility and severity of ADEs.  
Limitations 
This analysis may underestimate ADE hospitalization due to the underreporting of 
ADEs in administrative datasets (Cano & Rozenfeld, 2009; Hohl et al., 2013). However, 
studies have noted the utility of using administrative data in detecting adverse events 
(David W Bates et al., 2003; Cano & Rozenfeld, 2009; Hougland, Xu, Pickard, Masheter, 
& Williams, 2006; Weingart et al., 2000). This analysis was also restricted to six states, 
which limits the generalizability of its findings.   
We limited this analysis to ADE hospitalizations because they provide insight into 
the safety of ambulatory prescribing (Thürmann, 2003). However, the definition utilized 
in this study was broad and further analysis should indicate whether ADE hospitalizations 
are considered preventable, potential, or non-preventable. This distinction will allow for a 
better understanding of the performance of technologies, such as e-prescribing. Previous 
studies have found decreases in preventable and potential ADEs (D W Bates et al., 1998, 
1999). Also, while we only examined one HIT, e-prescribing, other technologies have 
also shown potential to decreasing ADEs and increasing patient safety. Given that e-
prescribing can be viewed as an entry-level system when compared to more 
comprehensive HITs, this study provides a stepping stone to determine the impact HIT 
adoption is having throughout our nation (Bell & Friedman, 2005). Lastly, we used an 
ecological measure for e-prescribing rates. This limited our ability to determine whether a 
patient with an ADE hospitalization was seen at a practice with e-prescribing capabilities.  
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Conclusions 
Our results suggest that county e-prescribing rates are currently not a significant 
factor in county-level ADE hospitalizations or the odds of having an ADE 
hospitalization. Further research and monitoring is necessary to determine the potential 
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We sought to determine whether increases in the proportion of physicians using 
electronic prescribing (e-prescribing) in a county were associated with decreases in the 
hospitalization rate for adverse drug events (ADE) among patients aged 65 and older. 
Methods.  
We examined 76 counties from Arizona, Florida, Maryland, New Jersey, and 
Washington, for which we had e-prescribing data for 2008 and 2011, using discharge 
data from the State Inpatient Databases. ADE discharge rates were calculated for adults 
65 years and older. E-prescribing data were obtained from the Office of the National 
Coordinator Health IT Dashboard; population data from the Area Health Resource File. 
Using negative binomial regression, we modeled the ADE hospitalization rate among 
older adults in 2011 based on the ADE hospitalization rate in 2008, the change in e-
prescribing rates, and county characteristics. 
Results.  
Change in e-prescribing rates was not significantly associated with the change in 
ADE hospitalization rates; no other county characteristics were found to be significant 
factors. As the 2008 ADE hospitalization rate increased by 1.0 per 1,000 older adults, the 




While the change in e-prescribing has not been associated with the change in 
ADE hospitalization rates, it may be too early to detect population-level changes due to 
the implementation of health information technologies, such as e-prescribing. 
Introduction 
Adverse drug events (ADEs), defined as injury or harm caused by a prescription 
medication, are of particular public health importance due to the increasing number of 
Americans taking prescription drugs. Nickel et al. (2013) estimate that for each additional 
drug taken by an individual there is a 10% increase in probability of suffering from a 
drug-related problem. Data in 2007-2010 indicate that approximately 67% of adults 65 
years and older took three or more prescription drugs within a 30 day time period (U.S. 
Department of Health and Human Services, 2013).  
Older adults also experience ADEs nearly seven times more often than adults 
youngers than 65 years (Lucado, Paez, & Elixhauser, 2011). The most serious type of 
ADE, an ADE resulting in hospitalization, reflects the safety and appropriateness of 
ambulatory prescribing (Thürmann, 2003). ADE hospitalizations are three times more 
likely to be present on admission than to occur during a hospital stay (Weiss, Elixhauser, 
Bae, & Encinosa, 2013). Preventing ADE hospitalizations and ensuring safe and 
appropriate prescribing measures are taken is vital to the safety of all patients in the U.S. 
healthcare system, particularly the elderly due to the multitude of chronic conditions they 
might suffer from resulting in polypharmacy making them an easy target for ADEs.  
One potential method to prevent ADEs is through the use of health information 
technologies (HITs), such as electronic prescribing (e-prescribing). E-prescribing is the 
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electronic transmission of prescription information from the point of patient care. This 
allows for the communication of prescriptions that are clean and free of ambiguities 
(Figge, 2009). Additionally, health care providers are able to decrease ADEs through the 
use of medication history tools that allow for drug-drug and drug-allergy interaction 
checks. These potential benefits, coupled with federal incentive programs, have resulted 
in an increase of e-prescribing from 7% in 2008 to 70% in 2014 (Gabriel & Swain, 2014).   
Using the Berwick, Nolan, & Whittington's (2008) Triple Aim call for the 
examination of population health impact and the Office of the National Health 
Coordinator’s (ONC) call for interoperability among all parts of the healthcare system, 
this study aims to examine the association between the change from 2008-2011 in e-
prescribing rates and the change in ADE hospitalizations among older adults at an 
ecological-level.  
Methodology 
Theoretical model  
 Ancker, Kern, Abramson, & Kaushal's (2012) Triangle Model was modified to 
take an ecological approach for this study (see Figure 2.2). The model builds on the 
classic Donabedian (1988) Structure-Process-Outcome framework to evaluate the impact 
of HIT on healthcare quality and patient safety. The five main constructs of this 
framework are innovation/technology, adopter/provider, health infrastructure, 
community, and consequences/outcomes.  
Data sources   
Three datasets were merged using the state and county Federal Information 
Processing Standards (FIPS) codes for this analysis: 2008 and 2011 Healthcare Cost and 
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Utilization Project (HCUP) State Inpatient Databases (SID), the ONC Health IT 
Dashboard – Health IT Adoption and Use dataset, and the Health Resources and Services 
Administration Area Health Resource File (AHRF). This study was categorized as 
“exempt status” by the University of South Carolina Institutional Review Board, due to 
the use of de-identified secondary data. 
Study Sample 
The study was limited to the 166 counties in Arizona, Florida, Maryland, New 
Jersey, and Washington, due to budgetary constraints. These states were selected because 
they reported key data elements, such as ICD-9 diagnosis codes and present on admission 
indicators, in HCUP SID for both years of interest. Exclusion criteria at the discharge-, 
hospital-, and county-level are outlined in Table 5.1.  
Additionally, to avoid artificially low ADE hospitalization rates, if a hospital was 
excluded from the analysis, we excluded the entire county in which the hospital was 
located. Twelve hospitals in 2011 and eleven hospitals in 2008 did not have county data 
available in SID. Using the patient county of residence with the highest percentage of 
discharges from the hospital, we attempted to determine the hospital county for these 23 
hospitals (See Appendix A). We ultimately decided not to exclude the counties of the 23 
hospitals with missing county data from the analysis because these hospitals made up less 
than 5% of all discharges in the most likely county. The final study population consisted 
of 76 counties.  
Table 5.1 Exclusion Criteria for association between 2008-2011 change in electronic 
prescribing and adverse drug event hospitalization rates analysis 
 
Discharge-level  
  missing age 
  missing present on admission (POA) information for non-missing diagnoses 
  missing county of residence 
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  patients younger than 65 years old 
  ICD-9 codes that pertain to accidental poisonings, self-inflicted poisonings, and/or 
assault 
  out-of-state patients 
  
Hospital-level 
  report all diagnoses as POA 
  over 20% of discharges with missing POA indicators for non-missing diagnoses 
  
County-level 
  missing electronic prescribing rates for either 2008 or 2011 
 
Dependent variable 
ADE hospitalizations were flagged by inverting the approach used by Encinosa & 
Bae (2013). Encinosa & Bae (2013) defined ADEs that occurred during a hospitalization 
as those discharges that [1] were not flagged as being present on admission (POA), but 
[2] did have one of the ICD-9 diagnosis codes listed by Lucado, Paez, & Elixhauser 
(2011). Rather than excluding discharges that were flagged as POA, we included those 
ADEs as having occurred outside of a hospitalization. That is, if a discharge had an ICD-
9 diagnosis code that was determined to be an ADE and had a POA indicator flagged, we 
determined that ADE to be acquired prior to hospitalization. ADEs that occurred during a 
hospitalization were not included in this analysis, as they were not representative of the 
safety of ambulatory prescribing. The county ADE hospitalization rate was calculated by 
dividing the number of ADE hospitalizations for older adults in the county by the older 
adult population in the county.  
Independent variable 
The percentage of physicians e-prescribing in each county was determined using the 
ONC Health IT Dashboard – Adoption and Use dataset. The ONC Health IT Dashboard 
provides the percentage of physicians e-prescribing on the largest e-prescribing network, 
Surescripts (Office of the National Coordinator for Health Information Technology, 
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2014). Surescripts information is used by over 95% of U.S. community pharmacies and 
provides functionalities to reduce the risk of ADEs and drug interactions (Surescripts, 
2014). The difference between the 2008 and 2011 e-prescribing rates were taken for each 
county and used as the main independent variable for this analysis.  
Control variables  
The multivariable analysis controlled for potential confounders in this study. 
County-level variables were gathered from the HRSA AHRF to represent each construct 
in our model. Adopters/providers are represented by the number of primary care 
physicians per 1,000 in the county (quartiles). The healthcare infrastructure of the county 
is represented by the number of hospital beds per 1,000 in the county (quartiles), whether 
the county has a hospital (categorized as 0 and 1 or more), and whether the county is 
designated as a whole county health professional shortage area (HPSA). Variables 
representing the community include the county location (urban/rural), the percentage of 
the population that is greater than or equal to 65 years old (quartiles), and the percentage 
of the population with less than a high school education (quartiles).   
Analytic Approach  
A pre- and post- ecological study design was used to determine the association 
between the change in e-prescribing rates and ADE hospitalization rates at the county-
level. Discharges were assigned to counties based on the patient county of residence. A 
comparison of study counties to other U.S. counties determined any differences among 
county characteristics. Differences among the independent and dependent variables based 
on county characteristics were also conducted separately using one-way analysis of 
variance (ANOVA) to determine if county characteristics were associated with changes 
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in either e-prescribing rates or ADE hospitalization rates. Lastly, a multivariate analysis 
was conducted using negative binomial regression to model the number of ADE 
hospitalizations for older adults in 2011. This model was offset by the natural logarithm 
of the population over 65 years old in the county. Covariates included the ADE rate for 
2008, the change in e-prescribing from 2008-2011, and county-level characteristics. The 
adjusted incident risk ratios (IRR) were calculated by the exponentiation of the model 
estimate.  
Results  
Table 5.2 compares the 76 studied counties to the remaining U.S. counties. 
Overall, studied counties had more primary care physicians (p<0.0001) and hospitals 
(p<0.0001), were less likely to be rural (p<0.0001), and had a larger population 
(<0.0001).  
Table 5.2 Study County Characteristics and other U.S. Counties, 2011 












      
Technology      
Change in Electronic 





 19.9 0.7750 
      
Adopters / Providers      
Number of primary care 
physicians 
164.8 241.9 70.8 254.3 <0.0001 
Primary care physicians (per 
1,000) 
0.6 0.3 0.5 0.4 0.0234 
      
Healthcare Infrastructure      
Number of hospitals in county 3.1 3.1 2.0 4.2 <0.0001 
Hospital beds (per 1,000) 2.5 1.9 3.3 4.7 0.9164 
      
Community      
Rural county (%)* 36.8 - 66.0 - <0.0001 
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Total population 232,673 261,568 95,673 316,725 <0.0001 
Population ≥ 65 years (%) 17.7 7.1 16.1 4.1 0.5816 
Population with < high school 
education (%) 
10.4 4.2 11.3 4.9 0.1453 
Note: 
Comparisons conducted using Wilcoxon-Mann-Whitney test for continuous variables  
*Comparisons conducted using Wald chi-square test for categorical variables 
1 
Change in e-prescribing rate based on 1,689 counties with available e-prescribing data 
 
The rate of e-prescribing increased from 7.3% in 2008 to 37.5% in 2011 among 
studied counties, with an average change of 30.2%. The number of hospitals in a county 
was a significant factor in determining the change in e-prescribing rate from 2008 to 2011 
(p=0.0059; See Table 5.3). Counties without a hospital had a greater increase in e-
prescribing adoption when compared to counties with 2 or more hospitals.  
Table 5.3 Change in Electronic Prescribing (e-Prescribing) between 2008 and 2011, 
by county characteristics (n=76 counties) 
Characteristics of Interest 
Change in e-
prescribing from 
 2008 – 20111 
p-value
2 
   
Adopters / Providers   
Primary care physicians (per 1,000)  0.8729 
0.00 – 0.43 33.3  
0.44 – 0.55 24.2  
0.56 – 0.72 30.8  
0.73 – 1.85 (referent) 32.0  
   
Healthcare Infrastructure   
Hospital beds (per 1,000)  0.2590 
0.00 – 1.35 37.1  
1.36 – 2.15 27.6  
2.16 – 3.02 25.6  
3.03 – 10.3 (referent) 32.9  
Number of hospitals  0.0059 
0 55.7  
1  34.6  
2 or more (referent) 26.6  
Health Professional Shortage Area (HPSA)   0.2460 
No HPSA 31.9  
Whole County HPSA 27.0  
   
Community   
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Location  0.1744 
Urban 32.3  
Rural 26.6  
Population ≥ 65 years (%)  0.8767 
9.3 – 12.3 (referent) 29.1  
12.4 – 15.9 29.0  
16.0 – 21.0 32.6  
21.1 – 45.5  30.7  
Population with < high school education (%)   0.2169 
3.4 – 7.4 (referent) 31.9  
7.5 – 9.3 31.5  
9.4 – 12.1 30.4  
12.2 – 22.7  27.0  
Notes:  
1
Calculated values are mean county level change: 2011 – 2008. 
2
 p-value tests significance of factor in estimating change in e-prescribing rate from 
2008-2011  
 
Bold indicates a significant difference from referent group (used ANOVA w/ Bonferroni 
adjustment α=0.05/k, where k is the number of multiple comparisons) 
 
Table 5.4 depicts whether the change in ADE hospitalization rates are associated 
with county characteristics. Overall, the ADE hospitalization rate decreased from 0.71 
per 1,000 persons in 2008 to 0.65 per 1,000 in 2011 (p=0.2033, data not in table). No 
county characteristics were associated with the change in ADE rate from 2008 to 2011.  
Table 5.4 Change in ADE Hospitalization Rate (per 1,000 older adults) between 
2008 and 2011 (n = 76 counties), by county characteristics 
Characteristics of Interest 
Change in ADE Rate 
from 
 2008 – 20111 
p-value
2 
   
Adopters / Providers   
Primary care physicians (per 1,000)  0.1272 
0.00 – 0.43 -0.18  
0.44 – 0.55 -0.04  
0.56 – 0.72 0.00  
0.73 – 1.85 (referent) 0.02  
   
Healthcare Infrastructure   
Hospital beds (per 1,000)  0.3845 
0.00 – 1.35 0.02  
1.36 – 2.15 -0.09  
2.16 – 3.02 0.00  
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3.03 – 10.3 (referent) -0.11  
Number of hospitals  0.2117 
0 -0.39  
1 -0.08  
2 or more -0.02  
Health Professional Shortage Area (HPSA)   0.9522 
No HPSA -0.05  
Whole County HPSA -0.05  
   
Community   
Location  0.2553 
Urban -0.02  
Rural -0.11  
Population ≥ 65 years (%)  0.6775 
9.3 – 12.3 (referent) 0.00  
12.4 – 15.9 -0.11  
16.0 – 21.0 -0.17  
21.1 – 45.5  0.04  
Population with < high school education (%)   0.1970 
3.4 – 7.4 (referent) 0.01  
7.5 – 9.3 0.02  
9.4 – 12.1 -0.02  
12.2 – 22.7  -0.21  
Notes:  
1
Calculated values are means  
2
 p-value tests significance of factor in estimating change in ADE hospitalization rate 
from 2008-2011 
 
No significant differences from referent group were found (used ANOVA w/ Bonferroni 
adjustment α=0.05/k, where k is the number of multiple comparisons) 
 
Multivariable analysis indicated that the only significant factor in determining the 
ADE hospitalization rate among older adults in 2011 was the 2008 ADE hospitalization 
rate. Model 1included the ADE hospitalization rate for 2008 and the change in e-
prescribing rate from 2008 to 2011. Only the ADE hospitalization rate for 2008 was 
shown as a significant factor in predicting the ADE hospitalization rate for 2011 in model 
1. Model 2 included county-level characteristics to describe the adopters/providers, 
healthcare infrastructure, and community. In model 2, as the ADE hospitalization rate for 
2008 increased by 1.0 per 1,000 older adults, the relative risk of ADE hospitalizations 
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among older adults multiplied by 1.84 (p<0.0001). No other characteristics were found to 
be significant factors.  
Table 5.5 Negative Binomial Regression for Number of Older Adult ADE 
Hospitalizations in 2011 (n = 76 counties) 
Characteristics of Interest 






     
ADE Hospitalization Rate (per 1,000) for 2008 1.712 0.0001 1.843 <0.0001 
     
Technology     
Change in Electronic Prescribing (e-
prescribing) Rate from 2008-2011 
0.996 0.1244 0.994 0.0678 
     
Adopters / Providers     
Primary care physicians (per 1,000)     
0.00 – 0.43   1.023 0.8603 
0.44 – 0.55   1.008 0.9386 
0.56 – 0.72   0.972 0.7671 
0.73 – 1.85 (referent)   Ref. Ref. 
     
Healthcare Infrastructure     
Number of hospitals     
0   0.583 0.3770 
1   1.022 0.8645 
2 or more (referent)   Ref. Ref. 
     
Community     
Rural   0.857 0.1735 
Population with < high school education (%)      
3.4 – 7.4 (referent)   Ref. Ref. 
7.5 – 9.3   1.035 0.7171 
9.4 – 12.1   1.145 0.2610 
12.2 – 22.7    0.848 0.2301 
Notes:  
a 
Incident Rate Ratios (IRR) were calculated by the exponentiation of the model estimate 
 
Discussion 
The adjusted negative binomial regression revealed that the change in e-
prescribing rate was not a significant factor in the change in ADE hospitalization rates 
from 2008-2011. The ADE hospitalization rate for 2008 was a significant factor in 
determining the ADE hospitalization rate from 2011.  
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The rate of e-prescribing has increased dramatically nationwide since 2008 
(Gabriel & Swain, 2014). Two key policies, the Medicare Improvements for Patients and 
Providers Act and the Medicare and Medicaid Electronic Health Record incentive 
programs, have provided financial incentives to encourage providers to use e-prescribing. 
In our studied counties, the rate of e-prescribing increased from 7.3% in 2008 to 37.5% in 
2011. Low adoption rates within our sample of counties indicate that a majority of 
providers were not using e-prescribing, even in 2011. However, the e-prescribing county-
level rates in our sample were not significantly different from other U.S. counties.  
Though we had hypothesized that as the rate of e-prescribing increased from 2008 
to 2011, the rate of ADE hospitalizations would decrease at the county-level, we believe 
the low e-prescribing adoption rates may have inhibited our ability to see such an 
association. Under Rogers' (1995) Diffusion of Innovation theory, our 2008 study sample 
forms the innovators and early adopters and our 2011 study sample forms the early 
adopters and early majority of e-prescribing adopters. Studies have shown that  early 
adopters are more likely to alter the technology to improve their organizational 
efficiencies (Westphal & Shortell, 2014). The physicians in our study counties, as early 
adopters, may have been adapting the technologies to their organizational needs. The 
focus on long-term benefits may have prevented our ability to demonstrate an association 
with short-term benefits in ADE hospitalization rates. Since e-prescribing can be viewed 
as an entry level HIT, continued research and monitoring may indicate benefits over the 





The inherent limitations of using an administrative dataset that was generated for 
reimbursement purposes apply to this study (Bates et al., 2003). Though ADEs are 
underreported in administrative datasets, using ICD-9 diagnosis codes to identify ADEs 
is common practice (Hohl, Karpov, Reddekopp, & Stausberg, 2013). Only ADE 
hospitalizations that were acquired outside of the hospital were examined in this study, 
while ADEs can also present themselves within a hospital stay, in outpatient settings, and 
as treat-and-release emergency room visits (Honigman et al., 2001; Lucado et al., 2011; 
Weiss et al., 2013). However, Weiss, Elixhauser, Bae, & Encinosa (2013) found that 
ADEs are three times more likely to be present on admission than occur during a 
hospitalization.  
This study was limited to county-level characteristics and did not take individual 
patient characteristics into account. Individual patient characteristics, such as 
comorbidities and illness severity, have shown to increase the likelihood of adverse drug 
reactions (Sikdar et al., 2012). Additionally, the independent variable of interest, e-
prescribing rates, was an ecological measure that did not allow determination of which 
patients were seen by providers that used e-prescribing functionalities. Lastly, this study 
was limited to only counties within 5 states and the inherent differences among these 
counties when compared to other counties in the U.S. may limit the generalizability of 
these findings.  
Conclusion 
While the current study did not find an association between the change in e-
prescribing rates and the change in ADE hospitalization rates among older adults, it may 
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be too early to determine whether technologies are having a population health impact. As 
we continue to invest time and funding to the implementation of HITs, additional 
research and monitoring is necessary to determining whether a population-level benefit is 






The U.S. healthcare system has focused on improving patient safety and the 
quality of healthcare provision for over two decades. Implementation of health 
information technologies and their use in improving patient safety have been of great 
interest to health services researchers. This dissertation research examined the association 
between the county-level rate of electronic prescribing, a type of health information 
technology, and county-level rates of adverse drug events hospitalizations among older 
adults.  
Manuscripts one and two, represented as Chapters 4 and 5 of this document, were 
based on the analysis of 2008 and 2011 Healthcare Cost and Utilization Project State 
Inpatient Databased, the Office of the National Coordination Health IT Dashboard – 
Health IT Adoption and Use dataset, and the Health Resources and Services 
Administration (HRSA) Area Health Resource File (AHRF). Chapter 4 used a cross-
sectional ecological- and discharge- level analysis to determine the association between 
county e-prescribing rates and ADE hospitalizations in 2011, and the odds that a 
discharge would be ADE-associated versus other causes in 2011, respectively. Chapter 5 
examined whether increased in the proportion of physicians using e-prescribing 
technologies in a county were associated with decreased in the hospitalization rate for 
ADEs among patients aged 65 years and older. 
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Results from chapter 4 indicated that county e-prescribing rates were not 1) 
significantly associated with county ADE hospitalization rates; 2) a significant factor in 
determining the odds of an ADE hospitalization. Similarly, chapter 5 results found that 
changes in e-prescribing rates at the county-level were not associated with the change in 
ADE hospitalization rates.  
While we hypothesized that the rate of e-prescribing would be associated with 
decreases in ADE hospitalization rates, we believe several factors may have inhibited our 
ability to detect such a difference. First, the rate of e-prescribing nationally for studied 
counties was approximately 37%. A low adoption rate would categorize these adopters as 
the “early majority” in Rogers’ Diffusion of Innovation theory (1995). These early 
adopters may be limited in their ability to obtain short-term benefits due to their focus on 
adapting technologies to improve long-term efficiencies. Second, we limited our analysis 
to ADE hospitalizations because of their ability to provide insight into the safety of 
ambulatory prescribing. However, the definition used did not allow for the identification 
of preventable, potential, and non-preventable ADE hospitalizations. Preventable and 
potential ADEs, in particular, have been shown to improve with the use of health 
information technologies. Third, we were unable to control for patient-level 
characteristics, such as number and type of chronic conditions, which may impact the 
types of medications taken and the usefulness of the technology to prevent ADEs. Lastly, 
we used an ecological measure for e-prescribing rates. This limited our ability to 
determine whether a patient with an ADE hospitalization was seen at a practice with e-
prescribing capabilities.  
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MED1078 447 04005 49.9 (223) 4.2 35.6 
MED0002 384 04013 5.5 (21) 0.1 3.1 
MED4271 2265 04013 84.0 (1903) 0.5 0.13 
MED4385 2126 04013 84.5 (1797) 0.4 0.38 
MED1576 1100 04013 7.1 (78) 0.2 3.4 
MED4019 399 04017 75.2 (300) 2.7 4.5 
FL 
00111520 12 11001 33.3 (4) 
(only county 




00104018 2648 12069 70.4 (1865) 5.2 2.0 
00100197 472 12086 79.2 (374) 0.1 0 
00110047 1035 12095 42.9 (444) 0.7 0.5 
00110051 710 12095 19.4 (138) 0.4 0.42 
23960083 3478 12095 39.9 (1388) 2.3 0.32 
2008 
AZ MED3555 27 04013 85.2 (23) 0.005 0 
FL 
23960061 709 12031 57.8 (410) 0.6 0.42 
00111526 43 12033 44.2 (19) 0.1 0 
00104018 2085 12069 75.9 (1582) 4.5 0 
00110044 854 12073 45.8 (391) 3.7 11.2 
23960083 79 12095 58.2 (46) 0.05 0 
00110047 631 12095 47.9 (302) 0.4 9.4 
00110051 539 12095 23.8 (128) 0.4 0.37 
00110022 1543 12111 37.1 (573) 4.2 0.39 
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